0001805077false12-31Q12024xbrli:sharesiso4217:USDiso4217:USDxbrli:shareseose:segmentxbrli:pureeose:interest_paymenteose:vote00018050772024-01-012024-03-310001805077us-gaap:CommonStockMember2024-01-012024-03-310001805077us-gaap:WarrantMember2024-01-012024-03-3100018050772024-05-0800018050772024-03-3100018050772023-12-3100018050772023-01-012023-03-310001805077us-gaap:NonrelatedPartyMember2024-01-012024-03-310001805077us-gaap:NonrelatedPartyMember2023-01-012023-03-310001805077us-gaap:RelatedPartyMember2024-01-012024-03-310001805077us-gaap:RelatedPartyMember2023-01-012023-03-310001805077us-gaap:CommonStockMember2022-12-310001805077us-gaap:AdditionalPaidInCapitalMember2022-12-310001805077us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001805077us-gaap:RetainedEarningsMember2022-12-3100018050772022-12-310001805077us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001805077us-gaap:CommonStockMember2023-01-012023-03-310001805077us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001805077us-gaap:RetainedEarningsMember2023-01-012023-03-310001805077us-gaap:CommonStockMember2023-03-310001805077us-gaap:AdditionalPaidInCapitalMember2023-03-310001805077us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001805077us-gaap:RetainedEarningsMember2023-03-3100018050772023-03-310001805077us-gaap:CommonStockMember2023-12-310001805077us-gaap:AdditionalPaidInCapitalMember2023-12-310001805077us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001805077us-gaap:RetainedEarningsMember2023-12-310001805077us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001805077us-gaap:CommonStockMember2024-01-012024-03-310001805077us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001805077us-gaap:RetainedEarningsMember2024-01-012024-03-310001805077us-gaap:CommonStockMember2024-03-310001805077us-gaap:AdditionalPaidInCapitalMember2024-03-310001805077us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001805077us-gaap:RetainedEarningsMember2024-03-310001805077eose:DOECleanEnergyFinancingProgramMemberus-gaap:NotesPayableOtherPayablesMember2023-08-310001805077us-gaap:TransferredAtPointInTimeMember2024-01-012024-03-310001805077us-gaap:TransferredAtPointInTimeMember2023-01-012023-03-310001805077us-gaap:TransferredOverTimeMember2024-01-012024-03-310001805077us-gaap:TransferredOverTimeMember2023-01-012023-03-310001805077eose:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001805077eose:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310001805077us-gaap:SecuredDebtMembereose:SeniorSecuredTermLoanAgreementMember2022-07-290001805077us-gaap:EquipmentMembersrt:MinimumMember2024-03-310001805077us-gaap:EquipmentMembersrt:MaximumMember2024-03-310001805077us-gaap:EquipmentMember2024-03-310001805077us-gaap:EquipmentMember2023-12-310001805077eose:FinanceLeaseMember2024-03-310001805077eose:FinanceLeaseMember2023-12-310001805077us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2024-03-310001805077us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2024-03-310001805077us-gaap:FurnitureAndFixturesMember2024-03-310001805077us-gaap:FurnitureAndFixturesMember2023-12-310001805077us-gaap:LeaseholdImprovementsMember2024-03-310001805077us-gaap:LeaseholdImprovementsMember2023-12-310001805077us-gaap:ToolsDiesAndMoldsMembersrt:MinimumMember2024-03-310001805077us-gaap:ToolsDiesAndMoldsMembersrt:MaximumMember2024-03-310001805077us-gaap:ToolsDiesAndMoldsMember2024-03-310001805077us-gaap:ToolsDiesAndMoldsMember2023-12-310001805077us-gaap:ConstructionInProgressMember2024-03-310001805077us-gaap:ConstructionInProgressMember2023-12-310001805077us-gaap:PatentsMember2024-03-310001805077us-gaap:PatentsMember2023-01-012023-03-310001805077us-gaap:PatentsMember2024-01-012024-03-310001805077eose:SoftwareMember2023-03-310001805077us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2024-03-310001805077us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-12-310001805077eose:ProductionTaxCreditsMember2024-01-012024-03-310001805077eose:ProductionTaxCreditsMember2023-01-012023-03-310001805077eose:ProductionTaxCreditsMember2024-03-310001805077eose:ProductionTaxCreditsMember2023-12-310001805077us-gaap:RelatedPartyMembereose:A2021ConvertibleNotesMember2021-07-310001805077us-gaap:RelatedPartyMembereose:A2021ConvertibleNotesMember2021-07-012021-07-310001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-01-310001805077us-gaap:RelatedPartyMemberus-gaap:CommonStockMembereose:IPOWarrantsMember2023-12-310001805077us-gaap:RelatedPartyMemberus-gaap:CommonStockMembereose:IPOWarrantsMember2024-03-310001805077eose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077eose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077us-gaap:SecuredDebtMembereose:SeniorSecuredTermLoanAgreementMember2024-03-310001805077us-gaap:SecuredDebtMembereose:SeniorSecuredTermLoanAgreementMember2023-12-310001805077eose:AFGConvertibleNoteMemberus-gaap:ConvertibleDebtMember2024-03-310001805077eose:AFGConvertibleNoteMemberus-gaap:ConvertibleDebtMember2023-12-310001805077eose:EquipmentFinancingFacilityMemberus-gaap:LineOfCreditMember2024-03-310001805077eose:EquipmentFinancingFacilityMemberus-gaap:LineOfCreditMember2023-12-310001805077eose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2021-07-060001805077eose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-01-012024-03-310001805077eose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-01-012023-03-310001805077us-gaap:RelatedPartyMembereose:A2021ConvertibleNotesMember2024-03-310001805077us-gaap:RelatedPartyMembereose:A2021ConvertibleNotesMember2023-12-310001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-01-180001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077eose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-01-180001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMember2023-01-180001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMember2023-01-012023-03-310001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-01-012024-03-310001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-01-012023-03-310001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMember2024-03-310001805077us-gaap:RelatedPartyMembereose:AFGConvertibleNotesMember2023-12-310001805077us-gaap:SecuredDebtMembereose:SeniorSecuredTermLoanAgreementMember2022-07-292022-07-290001805077srt:MinimumMembereose:SeniorSecuredTermLoanAgreementMembereose:SecuredOvernightFinancingRateSOFRMember2022-07-292022-07-290001805077eose:FederalReserveBankOfNewYorkFinancingRateNYFRBMembersrt:MinimumMembereose:SeniorSecuredTermLoanAgreementMember2022-07-292022-07-290001805077eose:SOFRLoansMembereose:SeniorSecuredTermLoanAgreementMember2022-07-292022-07-290001805077eose:ABRLoansMembereose:SeniorSecuredTermLoanAgreementMember2022-07-290001805077eose:SOFRLoansMembereose:SeniorSecuredTermLoanAgreementMember2024-03-310001805077us-gaap:SecuredDebtMemberus-gaap:NonrelatedPartyMembereose:SeniorSecuredTermLoanAgreementMember2024-01-012024-03-310001805077us-gaap:SecuredDebtMemberus-gaap:NonrelatedPartyMembereose:SeniorSecuredTermLoanAgreementMember2023-01-012023-03-310001805077us-gaap:SecuredDebtMemberus-gaap:NonrelatedPartyMembereose:SeniorSecuredTermLoanAgreementMember2024-03-310001805077us-gaap:SecuredDebtMemberus-gaap:NonrelatedPartyMembereose:SeniorSecuredTermLoanAgreementMember2023-12-310001805077eose:EquipmentFinancingFacilityMemberus-gaap:LineOfCreditMember2021-09-300001805077eose:EquipmentFinancingFacilityMemberus-gaap:LineOfCreditMember2021-09-012021-09-300001805077eose:EquipmentFinancingFacilityMemberus-gaap:LineOfCreditMember2022-09-012022-09-300001805077eose:EquipmentFinancingFacilityMemberus-gaap:LineOfCreditMember2022-09-300001805077eose:EquipmentFinancingFacilityMemberus-gaap:LineOfCreditMember2021-09-012024-03-310001805077eose:EquipmentFinancingFacilityMember2024-03-310001805077eose:EquipmentFinancingFacilityMember2023-12-310001805077eose:EquipmentFinancingFacilityMember2024-01-012024-03-310001805077eose:EquipmentFinancingFacilityMember2023-01-012023-03-310001805077us-gaap:RelatedPartyMembereose:YorkvilleConvertiblePromissoryNoteMemberus-gaap:ConvertibleDebtMember2022-12-012023-03-310001805077us-gaap:RelatedPartyMembereose:YorkvilleConvertiblePromissoryNoteMemberus-gaap:ConvertibleDebtMember2023-01-012023-03-310001805077eose:EmbeddedDerivativesYorkvilleConvertiblePromissoryNotesRelatedPartyMemberus-gaap:ConvertibleDebtMember2023-01-012023-03-310001805077us-gaap:RelatedPartyMembereose:April2023PrivateWarrantsMemberus-gaap:CommonStockMember2023-04-012023-04-300001805077us-gaap:RelatedPartyMembereose:April2023PrivateWarrantsMemberus-gaap:CommonStockMember2023-04-300001805077eose:May2023PrivateWarrantsMemberus-gaap:RelatedPartyMemberus-gaap:CommonStockMember2023-05-012023-05-310001805077eose:May2023PrivateWarrantsMemberus-gaap:RelatedPartyMemberus-gaap:CommonStockMember2023-05-310001805077eose:December2023WarrantsMemberus-gaap:RelatedPartyMemberus-gaap:CommonStockMember2023-12-012023-12-310001805077us-gaap:RelatedPartyMembereose:April2023PrivateWarrantsMemberus-gaap:CommonStockMember2024-03-310001805077us-gaap:RelatedPartyMembereose:April2023PrivateWarrantsMemberus-gaap:CommonStockMember2023-12-310001805077eose:May2023PrivateWarrantsMemberus-gaap:RelatedPartyMemberus-gaap:CommonStockMember2024-03-310001805077eose:May2023PrivateWarrantsMemberus-gaap:RelatedPartyMemberus-gaap:CommonStockMember2023-12-310001805077eose:December2023WarrantsMemberus-gaap:RelatedPartyMemberus-gaap:CommonStockMember2024-03-310001805077eose:December2023WarrantsMemberus-gaap:RelatedPartyMemberus-gaap:CommonStockMember2023-12-310001805077us-gaap:FairValueInputsLevel1Member2024-03-310001805077us-gaap:FairValueInputsLevel2Member2024-03-310001805077us-gaap:FairValueInputsLevel3Member2024-03-310001805077us-gaap:FairValueInputsLevel1Member2023-12-310001805077us-gaap:FairValueInputsLevel2Member2023-12-310001805077us-gaap:FairValueInputsLevel3Member2023-12-310001805077us-gaap:FairValueInputsLevel1Memberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2024-03-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMemberus-gaap:FairValueInputsLevel2Member2024-03-310001805077us-gaap:FairValueInputsLevel3Memberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2024-03-310001805077us-gaap:FairValueInputsLevel1Memberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2023-12-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001805077us-gaap:FairValueInputsLevel3Memberus-gaap:EmbeddedDerivativeFinancialInstrumentsMember2023-12-310001805077us-gaap:MeasurementInputExpectedTermMembereose:April2023PrivateWarrantsMember2024-03-310001805077us-gaap:MeasurementInputExpectedTermMembereose:April2023PrivateWarrantsMember2023-12-310001805077eose:April2023PrivateWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-03-310001805077eose:April2023PrivateWarrantsMemberus-gaap:MeasurementInputSharePriceMember2023-12-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:April2023PrivateWarrantsMember2024-03-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:April2023PrivateWarrantsMember2023-12-310001805077eose:April2023PrivateWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-03-310001805077eose:April2023PrivateWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2023-12-310001805077us-gaap:MeasurementInputExpectedTermMembereose:May2023PrivateWarrantsMember2024-03-310001805077us-gaap:MeasurementInputExpectedTermMembereose:May2023PrivateWarrantsMember2023-12-310001805077eose:May2023PrivateWarrantsMemberus-gaap:MeasurementInputSharePriceMember2024-03-310001805077eose:May2023PrivateWarrantsMemberus-gaap:MeasurementInputSharePriceMember2023-12-310001805077eose:May2023PrivateWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-03-310001805077eose:May2023PrivateWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2023-12-310001805077eose:May2023PrivateWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2024-03-310001805077eose:May2023PrivateWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2023-12-310001805077us-gaap:MeasurementInputExpectedTermMembereose:December2023PrivateWarrantsMember2024-03-310001805077us-gaap:MeasurementInputExpectedTermMembereose:December2023PrivateWarrantsMember2023-12-310001805077us-gaap:MeasurementInputSharePriceMembereose:December2023PrivateWarrantsMember2024-03-310001805077us-gaap:MeasurementInputSharePriceMembereose:December2023PrivateWarrantsMember2023-12-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:December2023PrivateWarrantsMember2024-03-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:December2023PrivateWarrantsMember2023-12-310001805077us-gaap:MeasurementInputPriceVolatilityMembereose:December2023PrivateWarrantsMember2024-03-310001805077us-gaap:MeasurementInputPriceVolatilityMembereose:December2023PrivateWarrantsMember2023-12-310001805077eose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-01-012023-12-310001805077us-gaap:MeasurementInputExpectedDividendRateMembereose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077us-gaap:MeasurementInputExpectedDividendRateMembereose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077us-gaap:MeasurementInputPriceVolatilityMembereose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077us-gaap:MeasurementInputPriceVolatilityMembereose:A2021ConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077eose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-01-012024-03-310001805077eose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-01-012023-12-310001805077us-gaap:MeasurementInputExpectedDividendRateMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077us-gaap:MeasurementInputExpectedDividendRateMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077us-gaap:MeasurementInputRiskFreeInterestRateMembereose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077eose:AFGConvertibleNotesMemberus-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ConvertibleDebtMember2024-03-310001805077eose:AFGConvertibleNotesMemberus-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ConvertibleDebtMember2023-12-310001805077eose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2024-03-310001805077eose:AFGConvertibleNotesMemberus-gaap:ConvertibleDebtMember2023-12-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2023-12-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2022-12-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2024-01-012024-03-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2023-01-012023-03-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2024-03-310001805077us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2023-03-310001805077us-gaap:WarrantMember2023-12-310001805077us-gaap:WarrantMember2022-12-310001805077us-gaap:WarrantMember2024-01-012024-03-310001805077us-gaap:WarrantMember2023-01-012023-03-310001805077us-gaap:WarrantMember2024-03-310001805077us-gaap:WarrantMember2023-03-310001805077us-gaap:NotesReceivableMember2024-03-310001805077us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2024-03-310001805077us-gaap:NotesReceivableMember2023-12-310001805077us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2023-12-310001805077eose:A2021ConvertibleNotesMember2024-03-310001805077us-gaap:FairValueInputsLevel3Membereose:A2021ConvertibleNotesMember2024-03-310001805077eose:A2021ConvertibleNotesMember2023-12-310001805077us-gaap:FairValueInputsLevel3Membereose:A2021ConvertibleNotesMember2023-12-310001805077eose:SeniorSecuredTermLoanAgreementMember2024-03-310001805077us-gaap:FairValueInputsLevel3Membereose:SeniorSecuredTermLoanAgreementMember2024-03-310001805077eose:SeniorSecuredTermLoanAgreementMember2023-12-310001805077us-gaap:FairValueInputsLevel3Membereose:SeniorSecuredTermLoanAgreementMember2023-12-310001805077eose:AFGConvertibleNotesMember2024-03-310001805077us-gaap:FairValueInputsLevel3Membereose:AFGConvertibleNotesMember2024-03-310001805077eose:AFGConvertibleNotesMember2023-12-310001805077us-gaap:FairValueInputsLevel3Membereose:AFGConvertibleNotesMember2023-12-310001805077us-gaap:FairValueInputsLevel3Membereose:EquipmentFinancingFacilityMember2024-03-310001805077us-gaap:FairValueInputsLevel3Membereose:EquipmentFinancingFacilityMember2023-12-3100018050772024-02-012024-02-0100018050772024-01-312024-01-310001805077us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001805077us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001805077us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310001805077us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001805077us-gaap:RestrictedStockUnitsRSUMember2024-03-3100018050772020-05-220001805077eose:PublicWarrantsMember2023-12-310001805077eose:PublicWarrantsMember2024-03-310001805077us-gaap:PrivatePlacementMember2023-01-012023-03-310001805077eose:AtTheMarketProgramMember2024-03-310001805077eose:AtTheMarketProgramMember2024-01-012024-03-310001805077eose:AtTheMarketProgramMember2023-01-012023-03-310001805077us-gaap:StockCompensationPlanMember2024-01-012024-03-310001805077us-gaap:StockCompensationPlanMember2023-01-012023-03-310001805077us-gaap:WarrantMember2024-01-012024-03-310001805077us-gaap:WarrantMember2023-01-012023-03-310001805077us-gaap:ConvertibleDebtSecuritiesMember2024-01-012024-03-310001805077us-gaap:ConvertibleDebtSecuritiesMember2023-01-012023-03-310001805077eose:ProductionTaxCreditsMemberus-gaap:SubsequentEventMember2024-04-22


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from   to

Commission file number 001-39291
EOS ENERGY ENTERPRISES, INC.
(Exact name of registrant as specified in its charter)
Delaware84-4290188
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
3920 Park Avenue
EdisonNJ08820
(Address of Principal Executive Offices)(Zip Code)
(732) 225-8400
Registrant’s telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per shareEOSEThe Nasdaq Stock Market LLC
Warrants, each exercisable for one share of common stockEOSEWThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes    No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes   ☐     No  
The registrant had outstanding 208,127,550 shares of common stock as of May 8, 2024.


Table of Contents
Page
Unaudited Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023
Item 1a.
1

FORWARD-LOOKING INFORMATION
All statements included in this Quarterly Report on Form 10-Q (“Quarterly Report”), other than statements or characterizations of historical fact, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements appear in a number of places in this Quarterly Report and include statements regarding the intent, belief or current expectations of Eos Energy Enterprises, Inc. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected. Factors which may cause actual results to differ materially from current expectations include, but are not limited to:    
changes adversely affecting the business in which we are engaged;
our ability to forecast trends accurately;
our ability to generate cash, service indebtedness and incur additional indebtedness;
our ability to raise financing in the future;
our customer’s ability to secure project financing;
the amount of final tax credits available to our customers or to Eos Energy Enterprises, Inc. pursuant to the Inflation Reduction Act;
uncertainties around our ability to meet the applicable conditions precedent and secure final approval of a loan in a timely manner or at all from the Department of Energy, Loan Programs Office, or the timing of funding and the final size of any loan that is approved;
the possibility of a government shutdown while we work to meet the applicable conditions precedent and finalize loan documents with the U.S. Department of Energy Loan Programs Office or while we await notice of a decision regarding the issuance of a loan from the Department of Energy Loan Programs Office;
our ability to continue to develop efficient manufacturing processes to scale and to forecast related costs and efficiencies accurately;
fluctuations in our revenue and operating results;
competition from existing or new competitors;
our ability to convert firm order backlog and pipeline to revenue;
risks associated with security breaches in our information technology systems;
risks related to legal proceedings or claims;
risks associated with evolving energy policies in the United States and other countries and the potential costs of regulatory compliance;
risks associated with changes to the U.S. trade environment;
risks resulting from the impact of global pandemics, including the novel coronavirus, Covid-19;
our ability to maintain the listing of our shares of common stock on NASDAQ;
our ability to grow our business and manage growth profitably, maintain relationships with customers and suppliers and retain our management and key employees;
risks related to adverse changes in general economic conditions, including inflationary pressures and increased interest rates;
risk from supply chain disruptions and other impacts of geopolitical conflict;
changes in applicable laws or regulations; and
2

other factors detailed under the section entitled “Risk Factors” herein.
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. See also Part I, Item 1A, “Risk Factors” disclosures contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 for additional discussion of the risks and uncertainties that could cause the Company’s actual results to differ materially from those expressed or implied in its forward-looking statements.









3

Part I - Financial Information
EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)

March 31,
2024
December 31,
2023
ASSETS 
Current assets:  
Cash and cash equivalents$31,773 $69,473 
Restricted cash2,625 3,439 
Accounts receivable, net 3,953 3,387 
Inventory, net14,393 17,070 
Vendor deposits6,513 7,161 
Contract assets, current11,075 6,386 
Prepaid expenses1,278 1,082 
Grant receivable
4,798 3,256 
Other receivables
7,500 7,500 
Other current assets3,110 3,577 
Total current assets87,018 122,331 
Property, plant and equipment, net42,742 37,855 
Intangible assets, net282 295 
Goodwill4,331 4,331 
Operating lease right-of-use asset, net3,735 4,033 
Long-term restricted cash11,858 11,755 
Other assets, net
5,716 5,892 
Total assets$155,682 $186,492 
LIABILITIES
Current liabilities:
Accounts payable $18,339 $20,540 
Accrued expenses38,614 32,332 
Operating lease liability, current 1,574 1,496 
Long-term debt, current 3,458 3,332 
Contract liabilities, current 2,828 3,070 
Other current liabilities108 100 
Total current liabilities64,921 60,870 
Long-term liabilities:
Operating lease liability2,922 3,350 
Long-term debt88,222 88,002 
Convertible notes payable - related party113,950 112,525 
Interest payable - related party2,892  
Contract liabilities, long-term4,283 3,540 
Warrants liability
24,561 27,461 
Other liabilities1,604 1,544 
Total long-term liabilities238,434 236,422 
Total liabilities303,355 297,292 
4

EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
March 31,
2024
December 31,
2023
COMMITMENTS AND CONTINGENCIES (NOTE 15)
SHAREHOLDERS' DEFICIT
Common stock, $0.0001 par value, 300,000,000 shares authorized, 206,779,447 and 199,133,827 shares outstanding on March 31, 2024 and December 31, 2023, respectively
22 21 
Preferred stock, $0.0001 par value, 1,000,000 shares authorized, no shares outstanding on March 31, 2024 and December 31, 2023
  
Additional paid in capital774,857 765,018 
Accumulated deficit(922,554)(875,846)
Accumulated other comprehensive income2 7 
Total shareholders' deficit(147,673)(110,800)
Total liabilities and shareholders' deficit$155,682 $186,492 
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
5

EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share and per share amounts)
Three Months Ended March 31,
 20242023
Revenue
Total revenue$6,601 $8,835 
Costs and expenses
Cost of goods sold28,229 26,940 
Research and development expenses5,200 5,445 
Selling, general and administrative expenses14,242 13,955 
Loss from write-down of property, plant and equipment65 760 
Total costs and expenses47,736 47,100 
Operating loss(41,135)(38,265)
Other (expense) income
Interest expense, net(4,267)(4,829)
Interest expense - related party(4,851)(13,755)
Change in fair value of warrants
2,900 (156)
Change in fair value of derivatives - related parties
534 (12,934)
Loss on debt extinguishment (1,634)
Other income (expense)
136 (17)
Loss before income taxes
$(46,683)$(71,590)
Income tax expense
25 10 
Net loss
$(46,708)$(71,600)
Other comprehensive income
Foreign currency translation adjustment, net of tax(5)1 
Comprehensive loss
$(46,713)$(71,599)
Basic and diluted loss per share attributable to common shareholders
Basic$(0.23)$(0.82)
Diluted$(0.23)$(0.82)
Weighted average shares of common stock
Basic201,306,905 86,797,669 
Diluted201,306,905 86,797,669 
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
6

EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT
(In thousands, except share and per share amounts)
Common StockAdditional Paid in capital
Accumulated Other Comprehensive Income (Loss)
Accumulated DeficitTotal
SharesAmount
Balances on December 31, 2022
82,653,781 $9 $513,614 $6 $(646,340)$(132,711)
Stock-based compensation— — 3,363 — — 3,363 
Release of restricted stock units915,206 — — — — — 
Cancellation of shares used to settle payroll tax withholding(246,717)— (345)— — (345)
Issuance of common stock11,900,400 1 25,694 — — 25,695 
Foreign currency translation adjustment— — — 1 — 1 
Net loss— — — — (71,600)(71,600)
Balances on March 31, 2023
95,222,670 $10 $542,326 $7 $(717,940)$(175,597)
Balances on December 31, 2023
199,133,827 $21 $765,018 $7 $(875,846)$(110,800)
Stock-based compensation— — 2,941 — — 2,941 
Release of restricted stock units657,605 — — — — — 
Cancellation of shares used to settle payroll tax withholding(251,967)— (308)— — (308)
Issuance of common stock 7,239,982 1 7,206 — — 7,207 
Foreign currency translation adjustment— — — (5)— (5)
Net loss— — — — (46,708)(46,708)
Balances on March 31, 2024
206,779,447 $22 $774,857 $2 $(922,554)$(147,673)
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
7

EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, except share and per share amounts)
Three Months Ended March 31,
 
2024
2023
Cash flows from operating activities  
Net loss$(46,708)$(71,600)
Adjustment to reconcile net loss to net cash used in operating activities
Stock-based compensation2,941 3,363 
Depreciation and amortization1,197 2,686 
Loss on debt extinguishment 1,634 
Loss from write-down of property, plant and equipment 65 760 
Amortization of right-of-use assets298 233 
Non-cash interest expense885 915 
Non-cash interest expense - related party1,549 11,338 
Change in fair value of warrants
(2,900)156 
Change in fair value of derivatives - related parties
(534)12,934 
Changes in operating assets and liabilities:
Prepaid expenses(196)406 
Inventory2,677 9,185 
Accounts receivable(566)(1,984)
Vendor deposits(204)(917)
Contract assets(4,572)(1,914)
Grant receivable
(1,542)(780)
Accounts payable(2,593)(208)
Accrued expenses6,159 4,991 
Interest payable - related party2,892 2,417 
Operating lease liabilities(350)(262)
Contract liabilities501 (3,450)
   Other 527 (381)
Net cash used in operating activities(40,474)(30,478)
Cash flows from investing activities
Purchases of property, plant and equipment(4,042)(2,897)
Net cash used in investing activities(4,042)(2,897)
Cash flows from financing activities
Principal payments on finance lease obligations(2)(7)
Proceeds from issuance of convertible notes - related party 33,350 
Payment of debt issuance costs - related party
 (1,116)
Repayment of equipment financing facility(786)(677)
Proceeds from issuance of common stock
7,207 1,250 
Repurchase of shares from employees for income tax withholding purposes(308)(345)
Net cash provided by financing activities6,111 32,455 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(6)(1)
8

EOS ENERGY ENTERPRISES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, except share and per share amounts)
Three Months Ended March 31,
 
2024
2023
Net decrease in cash, cash equivalents and restricted cash
(38,411)(921)
Cash, cash equivalents and restricted cash, beginning of the period84,667 31,223 
Cash, cash equivalents and restricted cash, end of the period$46,256 $30,302 
Non-cash investing and financing activities
Accrued and unpaid capital expenditures$384 $603 
Issuance of common stock upon settlement of Yorkville convertible notes 24,422 
Accrued and unpaid capitalized internal-use software8 130 
Supplemental disclosures
Cash paid for interest$238 $3,690 
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.
9


EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)

1.Overview
Nature of Operations
Eos Energy Enterprises, Inc. (the “Company,” “we,” “us,” “our,” and “Eos”) designs, develops, manufactures and markets innovative energy storage solutions for utility-scale, microgrid and commercial & industrial (“C&I”) applications. Eos developed a broad range of intellectual property with multiple patents covering unique battery chemistry, mechanical product design, energy block configuration and a software operating system (Battery Management System). The Company has only one operating and reportable segment.
Liquidity and Going Concern
As a growth company in the early commercialization stage of its lifecycle, Eos is subject to inherent risks and uncertainties associated with the development of an enterprise. In this regard, substantially all of the Company’s efforts to date have been devoted to the development and manufacturing of battery energy storage systems and complimentary products and services, recruitment of management and technical staff, deployment of capital to expand the Company’s operations to meet customer demand and raising capital to fund the Company’s development. As a result of these efforts, the Company has incurred significant losses and negative cash flows from operations since its inception and expects to continue to incur such losses and negative cash flows for the foreseeable future until such time that the Company can reach a scale of profitability to sustain its operations.
In order to execute its development strategy, the Company has historically relied on outside capital through the issuance of equity, debt and borrowings under financing arrangements (collectively “outside capital”) to fund its cost structure and expects to continue to rely on outside capital for the foreseeable future. While the Company believes it will eventually reach a scale of profitability to sustain its operations, there can be no assurance the Company will be able to achieve such profitability or do so in a manner that does not require its continued reliance on outside capital. Moreover, while the Company has historically been successful in raising outside capital, there can be no assurance the Company will be able to continue to obtain outside capital in the future or do so on terms that are acceptable to the Company.
As of the date the accompanying Unaudited Condensed Consolidated Financial Statements were issued (the “issuance date”), management evaluated the significance of the following negative financial conditions in accordance with Accounting Standard Codification 205-40, Going Concern:
Since its inception, the Company has incurred significant losses and negative cash from operations in order to fund its development. During the three months ended March 31, 2024, the Company incurred a net loss of $46,708, incurred negative cash flows from operations of $40,474 and had an accumulated deficit of $922,554 as of March 31, 2024.
As of March 31, 2024, the Company had $31,773 of unrestricted cash and cash equivalents available to fund the Company’s operations and working capital of $22,097, inclusive of $3,458 of outstanding debt that is currently scheduled to mature within the next twelve months. Additionally, the Company has no additional borrowings available under pre-existing financing arrangements to fund its operations (see Note 12, Borrowings).
The Company has available capacity under its at-the-market (“ATM”) offering program to issue shares of the Company’s common stock, (see also Note 18, Shareholders’ Deficit) to aid in funding the Company’s operations. However, the Company’s ability to secure such funding is dependent upon certain conditions, such as investors’ willingness to purchase the Company’s common stock and at a price that is acceptable to the Company. Accordingly, as of the issuance date, there is no assurance the Company will be able to secure funding under these pre-existing arrangements or on terms that are acceptable to the Company.
10

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)

1. Overview (cont.)
Similarly, while the Company has historically been successful in raising additional outside capital to fund the Company’s operations, as of the issuance date no assurance can be provided the Company will be successful in obtaining additional outside capital or on terms that are acceptable to the Company. In this regard, the Company continues to progress through the Department of Energy (“DOE”) Loan Programs Office’s (“LPO”) process for its Title XVII loan. In August 2023, the DOE issued a conditional commitment letter to the Company for a loan of an aggregate principal amount of up to $398,600 through the DOE’s Clean Energy Financing Program. Certain technical, legal and financial conditions must be met and due diligence to the satisfaction of the DOE must be completed before the DOE enters into definitive financing documents with the Company and funds the loan. There can be no assurance that the Company will be able to secure such a loan or on terms that are acceptable to the Company.
The Company is required to remain in compliance with a quarterly minimum financial liquidity covenant under its Senior Secured Term Loan Credit Agreement (“Senior Secured Term Loan”). While the Company was in compliance with this covenant as of March 31, 2024, the Company expects it may be unable to remain in compliance with this covenant beginning on June 30, 2024 and thereafter absent the Company’s ability to secure a waiver or raise additional outside capital. In the event the Company is unable to remain in compliance with the minimum financial liquidity covenant and the other nonfinancial covenants required by the Senior Secured Term Loan and the Company is further unable to cure such noncompliance or secure a waiver, the Lender - Atlas Credit Partners (ACP) Post Oak Credit I LLC (“Atlas”) may, at its discretion, exercise any and all of its existing rights and remedies, which may include, among other things, entering into a forbearance agreement with the Company and/or asserting its rights in the Company’s assets securing the loan. Moreover, the Company’s other lenders may exercise similar rights and remedies under the cross-default provisions of their respective borrowing arrangements with the Company.
Absent an ability to secure additional outside capital in the near term, the Company will be unable to meet its obligations as they become due over the next twelve months beyond the issuance date.
In the event the Company’s ongoing efforts to raise additional outside capital prove unsuccessful, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors and/or allowing the Company to become insolvent.
These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying Unaudited Condensed Consolidated Financial Statements do not include any adjustments that may result from the outcome of these uncertainties.
2. Summary of Significant Accounting Policies
Basis of Presentation
The accompanying Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its 100% owned, direct and indirect subsidiaries and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). All intercompany transactions and balances have been eliminated in the preparation of the Unaudited Condensed Consolidated Financial Statements. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The interim financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in our 2023 Annual Report on Form 10-K. These interim results are not necessarily indicative of results for the full year.
11

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
2. Summary of Significant Accounting Policies (cont.)
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassification of Prior Year Presentation
Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.
Recent Accounting Pronouncements
There were no new accounting standards or updates during the three months ended March 31, 2024 that would have a material impact on the Company’s Unaudited Condensed Consolidated Financial Statements.
3. Revenue Recognition
The Company primarily earns revenue from sales of its energy storage systems and services including installation, commissioning and extended warranty services. Product revenues, which are generally recognized at a point in time, and service revenues, which are generally recognized over time, are as follows:
For the Three Months Ended March 31,
20242023
Product revenue$6,501 $8,675 
Service revenue100 160 
Total revenues$6,601 $8,835 
For the three months ended March 31, 2024, the Company had one customer that accounted for 88.1% of total revenue; for the three months ended March 31, 2023, we had one customer that accounted for 97.0% of total revenue.
Lessor revenue
The Company leases battery energy storage systems to one customer through a sales-type lease with a 20-year term. No revenue was recognized from the sales-type lease for the three months ended March 31, 2024 and 2023.
Contract assets and Contract liabilities
The following table provides information about contract assets and contract liabilities from contracts with customers. Contract assets, current, Contract liabilities, current and Contract liabilities, long-term are included separately on the Unaudited Condensed Consolidated Balance Sheets and contract assets expected to be recognized in greater than twelve months are included under Other assets, net.
 
March 31, 2024
December 31, 2023
Contract assets$12,894 $8,322 
Contract liabilities$7,111 $6,610 
12

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
3. Revenue Recognition (cont.)
The Company recognizes contract assets for certain contracts in which revenue recognition performance obligations have been satisfied but invoicing to the customer has not yet occurred. Contract liabilities primarily relate to consideration received from customers in advance of the Company’s satisfying performance obligations under contractual arrangements. Contract balances are reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.
Contract assets increased by $4,572 during the three months ended March 31, 2024 due to recognition of revenues for which invoicing has not yet occurred. Contract liabilities increased by $501 during the three months ended March 31, 2024, reflecting $798 of revenue recognized from customers and offset by $1,299 in customer advance payments.
Contract liabilities of $2,828 as of March 31, 2024 are expected to be recognized within the next twelve months and long-term contract liabilities of $4,283 are expected to be recognized as revenue in greater than twelve months. Contract assets of $11,075 as of March 31, 2024 are expected to be recognized within the next twelve months and long-term contract assets of $1,819 are expected to be recognized as accounts receivable in greater than twelve months.
Remaining Performance Obligations
Remaining performance obligations (“RPO”) represent the allocated transaction price of unsatisfied or partially unsatisfied performance obligations. The Company expects to recognize revenue related to the RPOs as the performance obligations are satisfied in accordance with the Company’s revenue recognition policy, which can be found in Note 2, Summary of Significant Accounting Policies, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
4. Cash, Cash Equivalents and Restricted Cash
Restricted cash - current consists of escrow deposits related to U.S. Custom Bonds insurance and escrow deposits related to our credit card program agreements.
Long-term restricted cash relates to interest that is required to be held in escrow per the Senior Secured Term Loan Agreement in an amount equal to the next four quarterly interest payments owed as of the balance sheet date (see Note 12, Borrowings for further discussion).
The following table reconciles reported amounts from the Unaudited Condensed Consolidated Balance Sheets to Cash, Cash Equivalents and Restricted Cash reported within the Unaudited Condensed Consolidated Statements of Cash Flows:
March 31, 2024
March 31, 2023
Cash and cash equivalents$31,773 $16,127 
Restricted cash - current
2,625 2,725 
Long-term restricted cash11,858 11,450 
    Total cash, cash equivalents and restricted cash $46,256 $30,302 

13

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)

5. Inventory
The following table provides information about inventory balances:
 
March 31, 2024
December 31, 2023
Raw materials$13,045 $15,487 
Work-in-process490 1,105 
Finished goods858 478 
     Total inventory, net$14,393 $17,070 
6. Property, Plant and Equipment, Net
The following table provides information about property, plant and equipment, net balances:
 Estimated Useful lives
March 31, 2024
December 31, 2023
Equipment
5 to 10 years
$22,484 $20,559 
Finance lease
5 years
504 504 
Furniture
5 to 10 years
2,179 2,103 
Leasehold improvementsLesser of useful life/
remaining lease
7,951 7,718 
Tooling
2 to 3 years
7,866 7,045 
Construction in progress (“CIP”)
20,819 17,958 
     Total61,803 55,887 
Less: Accumulated depreciation (19,061)(18,032)
Total property, plant and equipment, net$42,742 $37,855 
Depreciation expense related to property, plant and equipment was $1,175 and $2,667 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, the Company recorded a loss from write-down of property, plant and equipment of $65 and $760, respectively, mainly due to replacement of equipment, outsourcing of certain production processes and the shift in production from the Gen 2.3 battery system to the Z3™ battery system.
Included in CIP assets are capitalized interest costs of $850 and $0 for the three months ended March 31, 2024 and 2023, respectively. Depreciation will commence after the assets under construction are placed in service.
7. Intangible Assets
Intangible assets include patents valued at $400, which represents the cost to acquire the patents. These patents are determined to have useful lives and are amortized into the results of operations over ten years. The Company recorded amortization expense of $10 for the three months ended March 31, 2024 and 2023 related to patents.
The Company capitalized $146 of costs for internal-use software, including $8 of costs capitalized during the three months ended March 31, 2024. The software has a useful life and is amortized into the results of operations over 3 years. The Company recorded amortization expense of $12 and $9 for the three months ended March 31, 2024 and 2023, respectively, related to software.
14

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
8. Notes Receivable, Net and Variable Interest Entities (“VIEs”) Consideration
Notes receivable, net, relates to financing the Company offered to a customer. The Company reports the notes receivable at the principal balance outstanding less an allowance for losses. The estimate of credit losses is based on historical trends, the customer’s financial condition and current economic trends. The Company charges interest at a fixed rate and calculates interest income by applying the effective rate to the outstanding principal balance.
The Company had notes receivable, net, of $827 and $863 outstanding as of March 31, 2024 and December 31, 2023, respectively. These amounts are included in Other assets, net and Other current assets in the accompanying Unaudited Condensed Consolidated Balance Sheets. As of March 31, 2024 and December 31, 2023, the allowance for expected credit loss related to the notes receivable amounted to $36 and $2, respectively.
The customer to whom the Company offers financing through notes receivable is a VIE. However, the Company is not the primary beneficiary, because the Company does not have power to direct the activities of the VIE that most significantly impact the VIE’s economic performance. Therefore, the VIE is not consolidated into the Company’s consolidated financial statements. The maximum loss exposure is limited to the carrying value of notes receivable as of the balances sheet dates.
9. Accrued Expenses
Accrued expenses were as follows:
March 31, 2024
December 31, 2023
Accrued payroll$7,273 $4,553 
Warranty reserve (1)
5,513 6,197 
Accrued legal and professional expenses11,058 10,710 
Provision for contract losses3,205 3,351 
Insurance premium payable, current2,730 2,605 
Interest payable, current
3,684  
Other5,151 4,916 
Total accrued expenses$38,614 $32,332 
(1) Refer to the table below for the warranty reserve activity for the three months ended March 31, 2024 and 2023.
The following table summarizes warranty reserve activity:

Three Months Ended March 31,
20242023
Warranty reserve - beginning of period$6,197 $3,836 
Additions for current period deliveries265 357 
Changes in the warranty reserve estimate(949) 
Warranty costs incurred (221)
Warranty reserve - end of period$5,513 $3,972 
10. Government Grants
Inflation Reduction Act of 2022 (“IRA”)
15

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
10. Government Grants (cont.)

On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 into law. The IRA has significant economic incentives for both energy storage customers and manufacturers for projects placed in service after December 31, 2022. Starting in 2023, there are Production Tax Credits under Internal Revenue Code 45X (“PTC”), that can be claimed on battery components manufactured in the U.S. and sold to U.S. or foreign customers. The tax credits available to manufacturers include a credit for ten percent of the cost incurred to make electrode active materials in addition to credits of $35 per kWh of capacity of battery cells and $10 per kWh of capacity of battery modules. These credits are cumulative, meaning that companies will be able to claim each of the available tax credits based on the battery components produced and sold through 2029, after which the PTC will begin to gradually phase down through 2032. In June 2023, the IRS issued temporary and proposed regulations related to applicable tax credit transferability and direct pay provisions of the Inflation Reduction Act. The Company has reviewed these regulations and believes they do not have a material impact on the financial statements.
Since the PTC is a refundable credit (i.e., a credit with a direct-pay option available), the PTC is outside the scope of ASC 740. Therefore, the Company accounts for the PTC under a government grant model. GAAP does not address the accounting for government grants received by a business entity that are outside the scope of ASC 740. The Company’s accounting policy is to analogize to IAS 20, Accounting for Government Grants and Disclosure of Government Assistance, under IFRS Accounting Standards. Under IAS 20, once it is reasonably assured that the entity will comply with the conditions of the grant, the grant money is recognized on a systematic basis over the periods in which the entity recognizes the related expenses or losses for which the grant money is intended to compensate. The Company recognizes grants once it is probable that both of the following conditions will be met: (1) the Company is eligible to receive the grant and (2) the Company is able to comply with the relevant conditions of the grant.
The PTC is recorded as the applicable items are produced and sold and the conditions in the preceding paragraph are met. For the three months ended March 31, 2024 and 2023, the Company recognized PTC of $1,542 and $798, respectively, as a reduction of cost of goods sold on the Unaudited Condensed Consolidated Statement of Operations and Comprehensive Loss. As of March 31, 2024 and December 31, 2023, grant receivable related to the PTC in the amount of $4,798 and $3,256, respectively, is recorded in the Unaudited Condensed Consolidated Balance Sheets.
11. Related Party Transactions
2021 Convertible Note Payable
In July 2021, the Company issued a convertible note in the aggregate principal amount of $100,000 to Spring Creek Capital, LLC, a wholly-owned, indirect subsidiary of Koch Industries, Inc. (the “2021 Convertible Note”). In connection with the 2021 Convertible Note, the Company paid $3,000 to B. Riley Securities, Inc., a related party, who acted as a placement agent. Refer to Note 12, Borrowings, for additional information.
AFG Convertible Notes
In January 2023, the Company issued and sold $13,750 of 26.5% Convertible Senior PIK Notes due in 2026 (“AFG Convertible Notes”) to Great American Insurance Company, Ardsley Partners Renewable Energy, LP, CCI SPV III, LP, Denman Street LLC, John B. Bending Irrevocable Children’s Trust, John B. Berding and AE Convert, LLC, a Delaware limited liability company managed by Russell Stidolph, a director of the Company (together, the “Purchasers”). In connection with the issuance and sale of the AFG Convertible Notes, the Company entered into an investment agreement (the “Investment Agreement”) with the Purchasers. Refer to Note 12, Borrowings, for additional information.
Standby Equity Purchase Agreement
On April 28, 2022, the Company entered into the Standby Equity Purchase Agreement (“SEPA”). Pursuant to the SEPA, the Company had the right, but not the obligation, to sell to Yorkville shares of its common stock at the Company’s request. On August 23, 2023, the Company and Yorkville terminated the SEPA, as amended, by mutual written consent. See Note 12, Borrowings for pre-advance loans in form of convertible promissory notes and Note 18, Shareholders' Deficit for additional information.
16

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
11. Related Party Transactions (cont.)
Warrants
The Company issued private placement warrants to B. Riley Financial, Inc. in conjunction with its initial public offering 2020 (“IPO warrants”). As of March 31, 2024 and December 31, 2023, 274,400 IPO warrants were outstanding for both periods, with a fair value of $49 and $55, respectively.
12. Borrowings

The Company’s debt obligations at carrying value consist of the following related and third-party borrowings:
March 31, 2024
December 31, 2023
Maturity DateBorrowing OutstandingCarrying Value*Borrowing OutstandingCarrying Value*
2021 Convertible Note Payable
June 2026
$115,815 $96,033 $115,815 $94,386 
Senior Secured Term Loan
March 2026
100,000 86,756 100,000 85,624 
AFG Convertible Notes
June 2026
17,429 17,917 17,429 18,139 
Equipment financing facility
April 2026
4,931 4,924 5,718 5,710 
    Total borrowings
238,175 205,630 238,962 203,859 
Current portion
3,458 3,458 3,332 3,332 
Total borrowings, non-current
$234,717 $202,172 $235,630 $200,527 
*Carrying value includes unamortized deferred financing costs, unamortized discounts and fair value of embedded derivative liabilities.
2021 Convertible Note Payable – Related Party
On July 6, 2021, the Company entered into an investment agreement with Spring Creek Capital, LLC, a wholly-owned, indirect subsidiary of Koch Industries, Inc. The investment agreement provides for the issuance and sale to Koch Industries of the 2021 Convertible Note in the aggregate principal amount of $100,000.
The 2021 Convertible Note contains an embedded derivative feature, which is presented on the Unaudited Condensed Consolidated Balance Sheets as a component of Convertible notes payable - related party. See Note 14, Fair Value Measurement for the assumptions used to determine the fair value of the embedded derivative as of March 31, 2024 and December 31, 2023.
Interest expense recognized on the 2021 Convertible Note is as follows:
Three Months Ended March 31,
2024
2023
Contractual interest expense$1,737 $1,637 
Amortization of debt discount1,531 1,207 
Amortization of debt issuance costs148 117 
    Total$3,416 $2,961 

The balances for the 2021 Convertible Note are as follows:
March 31, 2024
December 31, 2023
Principal$115,815 $115,815 
Unamortized debt discount(18,081)(19,612)
Unamortized debt issuance costs(1,747)(1,895)
Embedded conversion feature46 78 
     Aggregate carrying value$96,033 $94,386 
17

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
12. Borrowings (cont.)
The Company is obligated to repay all contractual interest attributable to the 2021 Convertible Note in-kind on a semi-annual basis, in accordance with the terms under the Senior Secured Term Loan. Therefore, as of March 31, 2024 and December 31, 2023, interest payable attributable to the 2021 Convertible Note was $1,737 and $0, respectively.
AFG Convertible Notes - Related Party
On January 18, 2023, the Company entered into the Investment Agreement with the Purchasers relating to the issuance and sale to the Purchasers of $13,750 in aggregate principal amount of the Company’s AFG Convertible Notes. The AFG Convertible Notes bear interest at a rate of 26.5% per annum, which is entirely paid-in-kind (“PIK Interest”) semi-annually in arrears on June 30 and December 30. It is expected that the Notes will mature on June 30, 2026, subject to earlier conversion, redemption or repurchase. The AFG Convertible Notes are convertible into shares of the Company’s common stock, par value $0.0001 per share, based on an initial conversion price of approximately $1.67 per share subject to customary anti-dilution and other adjustments. The Company has the right to settle conversions in shares of common stock, cash, or any combination thereof.
The Conversion Option includes an exercise contingency, which requires the Company to obtain shareholder approval for conversions subject to the Exchange Cap. If shareholder approval is not obtained, following commercially reasonable efforts, the Company will be required to settle the conversion in excess of the Exchange Cap in cash. Since settlement in cash may be required in absence of shareholder approval, the embedded conversion feature fails the equity classification guidance in ASC 815 and is thus precluded from being classified in equity. Therefore, the embedded conversion feature is required to be bifurcated from the AFG Convertible Notes and accounted for at fair value at each reporting date, with changes in fair value recognized on the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. The embedded derivative is presented on the Unaudited Condensed Consolidated Balance Sheets as a component of Convertible notes payable - related party. The fair value of the embedded derivative was $3,843 and $4,345 as of March 31, 2024 and December 31, 2023, respectively.
The fair value of the AFG Convertible Notes at issuance was $16,623, which was greater than the proceeds received. The Company recorded the difference of $2,873 as interest expense for the three months ended March 31, 2023 on the Unaudited Condensed Consolidated Statement of Operations and Comprehensive Loss.
Interest expense recognized on the AFG Convertible Notes is as follows:
Three Months Ended March 31,
2024
2023
Contractual interest expense$1,155 $779 
Amortization of debt discount218 148 
Amortization of debt issuance costs62 42 
    Total$1,435 $969 
The balances for the AFG Convertible Notes are as follows:
March 31, 2024
December 31, 2023
Principal$17,429 $17,429 
Unamortized debt discount(2,617)(2,835)
Unamortized debt issuance costs(738)(800)
Embedded conversion feature3,843 4,345 
     Aggregate carrying value$17,917 $18,139 
18

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
12. Borrowings (cont.)
The Company is obligated to repay all contractual interest attributable to the AFG Convertible Notes in-kind on a semi-annual basis, in accordance with the terms of the Investment Agreement. Therefore, as of March 31, 2024 and December 31, 2023, interest payable attributable to the AFG Convertible Notes was $1,155 and $0, respectively.
Senior Secured Term Loan
On July 29, 2022, the Company entered into a $100,000 Senior Secured Term Loan Credit Agreement with Atlas Credit Partners (ACP) Post Oak Credit I LLC, as administrative agent for the lenders and collateral agent for the secured parties. The Senior Secured Term Loan is scheduled to mature on the earlier of (i) July 29, 2026 and (ii) 91 days prior to the current maturity date of the 2021 Convertible Note of June 30, 2026. The Company has the right at any time to prepay any Borrowing in whole or in part in an amount of not less than $500.
The outstanding principal balance of the Senior Secured Term Loan bears interest, at the applicable margin plus, at the Company’s election, either (i) the benchmark secured overnight financing rate (“SOFR”), which is a per annum rate equal to (y) the Adjusted Term SOFR plus 0.2616%, or (ii) the alternate base rate (“ABR”), which is a per annum rate equal to the greatest of (x) the Prime Lending Rate, (y) the NYFRB Rate (as defined in the agreement) plus 0.5% and (z) the SOFR. The applicable margin under the Credit Agreement is 8.5% per annum with respect to SOFR loans and 7.5% per annum with respect to ABR loans. Interest on the Senior Secured Term Loan accrues at a variable interest rate and interest payments are due quarterly. The Company may elect to convert SOFR Loans to ABR and ABR Loans to SOFR. As of March 31, 2024, the interest rate in effect for the Senior Secured Term Loan interest payment was 14.11%.
Any repayment of principal prior to the second anniversary of the issuance date is subject to a call premium. The call premium is equal to the present value of all interest payments due through June 30, 2024, calculated using a discount rate equal to the applicable treasury rate as of the repayment date plus 50 basis points. The Company deemed that the fair value of the embedded derivative features which qualify for bifurcation was de minimis.
Additionally, interest is required to be escrowed based on the principle outstanding. This amount was $11,858 at March 31, 2024 and $11,755 at December 31, 2023. This escrowed and restricted cash is presented on a separate line item on the Unaudited Condensed Consolidated Balance Sheets as Long-term restricted cash.
The agreements also contain customary affirmative and negative covenants. They limit the Company’s and its subsidiaries’ ability to incur indebtedness, make restricted payments, including cash dividends on its common stock, make certain investments, loans and advances, enter into mergers and acquisitions, sell, assign, transfer or otherwise dispose of its assets, enter into transactions with its affiliates and engage in sale and leaseback transactions, among other restrictions. Furthermore, the limitation on the Company’s ability to incur indebtedness also requires payment of principal and interest in kind on the 2021 Convertible Note. While the Company was in compliance with this covenant as of March 31, 2024 , absent the Company’s ability to secure a waiver or raise additional outside capital, the Company expects it may be unable to remain in compliance with this covenant beginning on June 30, 2024 and thereafter (see Note 1, Overview for further discussion).
19

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
12. Borrowings (cont.)
The following table summarizes interest expense recognized:
Three Months Ended March 31,
2024
2023
Contractual interest expense$3,684 $3,373 
Amortization of debt discount115 93 
Amortization of debt issuance costs1,017 822 
Total $4,816 $4,288 
The Senior Secured Term Loan balance is as follows:
March 31, 2024
December 31, 2023
Principal$100,000 $100,000 
Unamortized debt discount(1,344)(1,459)
Unamortized debt issuance costs(11,900)(12,917)
     Aggregate carrying value$86,756 $85,624 
Equipment Financing facility
The Company entered into an agreement on September 30, 2021 with Trinity Capital Inc. (“Trinity”) for a $25,000 equipment financing facility, the proceeds of which will be used to acquire certain manufacturing equipment, subject to Trinity’s approval. Each draw is executed under a separate payment schedule (a “Schedule”) that constitutes a separate financial instrument. The financing fees included in each Schedule are established through monthly payment factors determined by Trinity. Such monthly payment factors are based on the Prime Rate reported in The Wall Street Journal in effect on the first day of the month in which a Schedule is executed. The Company has drawn a portion of the facility as follows:
Date of Draw
Gross Amount of Initial Draw
Coupon Interest RateDebt Issuance Costs
September 2021$7,000 14.3%$175 
September 20224,216 16.2%96 
    Total Equipment Financing loans$11,216 $271 
As of March 31, 2024 and December 31, 2023, total equipment financing carrying value was $4,924 and $5,710, respectively of which $3,458 and $3,332 are recorded as a current liability on the Unaudited Condensed Consolidated Balance Sheets, respectively. The Company recognized $208 and $317 for the three months ended March 31, 2024 and 2023 as interest expense attributable to the equipment financing agreement, respectively.
Yorkville Convertible Promissory Notes - Related Party
In December 2022, February 2023, and March of 2023, the Company issued additional convertible promissory notes with an aggregate principal amount of $22,000 in a private placement to Yorkville under the second and third supplemental agreements to the SEPA, respectively. The fair values of the January 2023 and February 2023 Promissory Notes at issuance were greater than the proceeds received. Accordingly, the Company recorded the excess of fair value of these Promissory Notes over the proceeds received as Interest expense - related party in the amount of $6,952, for the three months ended March 31, 2023, which is reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
20

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
12. Borrowings (cont.)
During the first quarter of 2023, Yorkville delivered Investor Notices requiring the Company to issue and sell an aggregate of 11,216,492 shares of common stock to Yorkville to offset all outstanding amounts owed to Yorkville under the outstanding Promissory Notes. The Company recognized a loss on debt extinguishment from the issuance of common stock from the December 2022, January 2023, and February 2023 Promissory Notes of $1,634 for the three months ended March 31, 2023, which is reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
The conversion feature for each of the Promissory Notes discussed above did not qualify for the scope exception to derivative accounting, therefore bifurcation was required for each issuance. Upon extinguishment of each Promissory Note, the embedded derivatives were adjusted to their fair value. This remeasurement resulted in net gains of $55 for the three months ended March 31, 2023, which is included in change in fair value of derivatives - related parties on the Condensed Consolidated Statements of Operations and Comprehensive Loss.
As of December 31, 2023, there were no outstanding amounts under the Yorkville Promissory Notes.
13. Warrants Liability
In April 2023, the Company issued 16,000,000 shares of common stock and 16,000,000 private placement warrants to purchase shares of common stock. In May 2023, the Company issued another 3,601,980 shares of common stock and 3,601,980 private placement warrants to purchase shares of common stock (the “April 2023 warrants” and “May 2023 warrants”, respectively).
In December 2023, the Company issued in a combined public offering 34,482,759 shares of common stock and 34,482,759 accompanying common warrants to purchase shares of common stock (the "December 2023 warrants").
The amount of warrants outstanding and fair value for all warrants as of March 31, 2024 and December 31, 2023 are as follows:
March 31, 2024
December 31, 2023
Warrants
Outstanding
Fair ValueWarrants
Outstanding
Fair Value
IPO warrants274,400 $49 274,400 $55 
April 2023 warrants16,000,000 5,494 16,000,000 6,276 
May 2023 warrants3,601,980 1,357 3,601,980 1,544 
December 2023 warrants34,482,759 17,661 34,482,759 19,586 
Total54,359,139$24,561 54,359,139$27,461 
All warrants are measured at fair value at each reporting period. For all warrants in aggregate, the change in fair value for the three months ended March 31, 2024 and 2023 has been recognized in change in fair value of warrants on the Company’s Condensed Consolidated Statements of Operations and Comprehensive Loss. The fair value for the warrants is included in Warrants liability on the Condensed Consolidated Balance Sheets. See Note 14, Fair Value Measurements for further information.
14. Fair Value Measurement
The Company’s financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, notes receivable, contract assets, accounts payable, warrants, convertible notes payable — related party, contract liabilities and long-term debt.
Accounting standards establish a hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels. The fair value hierarchy gives the highest priority to quoted market prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
21

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)

14. Fair Value Measurement (cont.)
Accounting standards require financial assets and liabilities to be classified based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and the exercise of this judgment may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.
The carrying value of cash and cash equivalents, restricted cash, accounts receivable, contract assets, contract liabilities and accounts payable are considered to be representative of their fair value due to the short maturity of these instruments.
The table below summarizes the fair values of certain liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and their designations among the three fair value measurement categories:
March 31, 2024
December 31, 2023
Level 1Level 2Level 3Level 1Level 2Level 3
Liabilities
  Warrants
$ $49 $24,512 $ $55 $27,406 
  Embedded derivatives
$ $ $3,889 $ $ $4,423 
Warrants Liabilities
The IPO warrants are classified as Level 2 financial instruments in the table above. They are valued on the basis of the quoted price of the Company’s public warrants, adjusted for insignificant difference between the public warrants and the private placement warrants.
The April 2023 warrants, May 2023 warrants and December 2023 warrants are classified as Level 3 financial instruments in the table above. The Company estimated the fair value of these warrants using the Black-Scholes model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, risk-free interest rate, volatility and time to expiration. The volatility involves unobservable inputs classified as Level 3 of the fair value hierarchy.
22

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)

14. Fair Value Measurement (cont.)
The inputs used to determine the fair value of the April 2023 warrants, May 2023 warrants and the December 2023 warrants are as follows:
April 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.54 years4.79 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
May 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.29 years4.54 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
December 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.71 years4.96 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
Embedded derivatives
The Company estimated the fair value of the embedded conversion features in the 2021 Convertible Note and the AFG Convertible Notes using a binomial lattice model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, dividend yield, risk-free interest rate, the effective debt yield and expected volatility. The effective debt yield and volatility involve unobservable inputs classified as Level 3 of the fair value hierarchy.
The inputs used to determine the fair value of the embedded derivative liabilities are as follows:
2021 Convertible Note Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield % %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
AFG Convertible Notes Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield % %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
23

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)

14. Fair Value Measurement (cont.)
Level 3 Liabilities

Level 3 liabilities are measured at fair value on a recurring basis using significant unobservable inputs. The following table summarizes the changes in the fair value of liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and are designated as Level 3:
Three Months Ended March 31,

2024
2023
Embedded derivatives
Balance at beginning of the period$4,423 $1,945 
Additions 14,799 
Change in fair value of derivatives - related parties1
(534)4,511 
Balance at end of the period$3,889 $21,255 
Warrants
Balance at beginning of the period$27,406 $ 
Additions  
Change in fair value of warrants
(2,894) 
Balance at end of the period$24,512 $ 
1 Includes loss on debt extinguishment from Yorkville Promissory Note Conversions for the three months ended March 31, 2023.

The estimated fair value of financial instruments not carried at fair value in the Unaudited Condensed Consolidated Balance Sheets was as follows:
Level in Fair Value Hierarchy
March 31, 2024
December 31, 2023
Carrying ValueFair ValueCarrying ValueFair Value
Notes receivable3$827 $721 $863 $719 
2021 Convertible Note*
396,033 63,034 94,386 57,998 
Senior Secured Term Loan 386,756 64,117 85,624 61,360 
AFG Convertible Notes*317,917 19,076 18,139 18,352 
Equipment financing facility34,924 4,261 5,710 4,826 
  Total$206,457 $151,209 $204,722 $143,255 
*Includes the embedded derivative liabilities.
15. Commitments and Contingencies
Lease Commitments
The Company has lease commitments under lease agreements. As of March 31, 2024, future lease payments amounted to $5,568.
Minimum Volume Commitment
In June 2022, the Company entered into a long-term supply agreement with a minimum volume commitment with a third party that provides services to process certain raw materials. Any purchase order issued under this supply agreement will be non-cancellable. If the Company fails to order the guaranteed minimum volume defined in the contract at the end of the term, the Company will be required to pay the counterparty an amount equal to the shortfall, if any, multiplied by a fee. The Company believes it will meet the minimum volume commitment and no shortfall penalty has been accrued as of March 31, 2024.
24

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
15. Commitments and Contingencies (cont.)
Legal Proceedings
Class Action Complaints
On March 8, 2023, a class action lawsuit was filed in the Court of Chancery of the State of Delaware by plaintiff Richard Delman against certain defendants including the Company’s former directors (the “Delman Defendants”). Neither the Company nor Eos Energy Storage LLC were named as a defendant but each was identified in the Complaint as a relevant non-party and the Company has indemnification obligations relating to the lawsuit. On February 1, 2024, the parties agreed to a binding Settlement Term Sheet (the “Settlement”) whereby plaintiff agreed to resolve the lawsuit in exchange for a settlement payment of $8,500, consisting of cash payments previously made by the Company of approximately $1,000 and an additional cash payment of approximately $7,500 funded by the Company’s Directors and Officers (“D&O”) liability insurance policies. The definitive settlement agreement is currently being negotiated between the parties. Once finalized, the settlement agreement will be submitted to the Court of Chancery for final approval.
On August 1, 2023, a class action lawsuit was filed in the United States District Court of New Jersey by plaintiff William Houck against the Company, the Company’s Chief Executive Officer, its former Chief Financial Officer and its current Chief Financial Officer (with the Company, the “Houck Defendants”). The Complaint alleges that the defendants violated federal securities laws by making knowingly false or misleading statements about the Company’s contractual relationship with a customer and about the size of the Company’s order backlog and commercial pipeline. Defendants deny the allegations and, on February 13, 2024, moved to dismiss the Complaint. On March 5, 2024, plaintiff filed an amended complaint that dropped the Company’s former Chief Financial Officer as a defendant. On April 4, 2024, defendants filed a renewed motion to dismiss the lawsuit. The Company intends to continue to vigorously defend against this action.
16. Stock-Based Compensation
Stock-based compensation expense included in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows:
Three Months Ended March 31,
2024
2023
Stock options$174 $740 
Restricted stock units2,767 2,623 
Total$2,941 $3,363 
The stock compensation expense has been recorded in cost of goods sold, research and development expenses and selling, general and administrative expenses.
As of March 31, 2024, total unrecognized compensation expense was $12,448 of which $12,358 was attributable to unvested restricted stock units (“RSU”) and $90 was attributable to unvested stock options. Compensation expense for these unvested awards is expected to be recognized over a weighted-average remaining vesting period of 2.1 years for RSUs and 0.1 years for stock options.
17. Income Taxes
For the three months ended March 31, 2024 and 2023, income tax expense was $25 and $10, respectively, related to state margin taxes and taxable earnings from foreign operations. The income tax expense differs from the amount computed by applying the statutory U.S. federal income tax rate of 21% to the loss before income taxes. This is due to non-taxable income, foreign operations and pre-tax losses for which no tax benefit can be recognized for U.S. income tax purposes.
25

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
17. Income Taxes (cont.)
The Company estimates and applies the annual effective tax rate to its ordinary earnings each interim period. Any significant unusual or infrequent items are not included in the estimation of the annual effective tax rate; instead, these items and their related income tax expense are separately stated in the interim period in which they occur. The quarterly estimate of the annual effective tax rate and related tax expense is subject to variation due to a multitude of factors, including, but are not limited to, the inability to accurately predict the Company’s pre-tax and taxable income and loss.
At each balance sheet date, management assesses the likelihood that the Company will be able to realize its deferred tax assets. Management considered all available positive and negative evidence in assessing the need for a valuation allowance. The realization of deferred tax assets depends on the generation of sufficient taxable income of the appropriate character and in the appropriate taxing jurisdiction during the future periods in which the related temporary differences become deductible. Management has determined that it is unlikely that the Company will be able to utilize its U.S. deferred tax assets at March 31, 2024 and December 31, 2023 due to cumulative losses. Therefore, the Company has a valuation allowance against its net U.S. deferred tax assets.
As of March 31, 2024 and December 31, 2023, the Company has unrecognized tax benefits associated with uncertain tax positions that, if recognized, would not affect the effective tax rate on income from continuing operations. The Company is not currently under examination by any taxing jurisdiction and none of the uncertain tax positions are expected to reverse within the next 12 months.
The Company files income tax returns in U.S. federal and various state jurisdictions, as well as in Italy and India. The open tax years for federal returns are 2020 and forward and open tax years for state returns are generally 2019 and forward. In addition, net operating losses generated in closed years and utilized in open years are subject to adjustment by the tax authorities.
18. Shareholders’ Deficit
Preferred Stock
The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors. At March 31, 2024 and December 31, 2023, there were no shares of preferred stock issued or outstanding.
Common Stock
The Company is authorized to issue 300,000,000 shares of common stock at $0.0001 par value as of March 31, 2024. The holders of the Company’s common stock are entitled to one vote for each share held. At March 31, 2024 and December 31, 2023, there were 206,779,447 and 199,133,827 shares of common stock issued and outstanding.
Treasury Stock
The Company recorded treasury stock of $308 and $345 for the three months ended March 31, 2024 and 2023 for shares withheld from employees to cover the payroll tax liability of RSUs vested, respectively. The treasury stock was immediately retired.
Warrants Liability
The Company has outstanding private warrants from the IPO warrants, the April 2023 warrants, the May 2023 warrants and the December 2023 warrants. Warrants liability is included separately on the Unaudited Condensed Consolidated Balance Sheets. See Note 13, Warrants Liability for further discussion.
26

EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
18. Shareholders’ Deficit (cont.)
Public Warrants
The Company sold warrants to purchase 9,075,000 shares of the Company’s common stock in a public offering on May 22, 2020 (the “Public Warrants”). Each Public Warrant entitles the holder to purchase a share of common stock at a price of $11.50 per share. There were no Public Warrants exercised during the three months ended March 31, 2024 and 2023. As of March 31, 2024 and December 31, 2023, there were 7,052,254 public warrants outstanding for both periods.
Standby Equity Purchase Agreement
During the three months ended March 31, 2023, total funds raised under the SEPA, inclusive of proceeds received from the Yorkville Convertible Promissory Notes, were $20,850. During the three months ended March 31, 2023, total shares issued under the SEPA were 11,900,400.
On August 23, 2023, the Company and Yorkville terminated the SEPA, as amended, by mutual written consent. At the time of termination, there were no outstanding borrowings, advance notices or shares of Common Stock to be issued under the SEPA. In addition, there were no fees due by the Company or Yorkville in connection with the termination of the SEPA.
At-the-Market Offering Program
The Company has a sales agreement with Cowen and Company, LLC (“Cowen”), with respect to an at-the-market offering (“ATM”) program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, having an aggregate offering price of up to $200,000 through Cowen as its sales agent and/or principal.
During the three months ended March 31, 2024, the Company sold 7,239,982 shares raising proceeds of $7,206, net of fees paid to Cowen, at an average selling price of $1.03 per share. There were no shares issued under the ATM offering program for the three months ended March 31, 2023.
Earnings Per Share
Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the weighted average number of shares of common stock outstanding during the period. Other potentially dilutive common shares and the related impact to earnings are considered when calculating EPS on a diluted basis. Since the Company incurred a net loss for the three months ended March 31, 2024 and 2023, the potential dilutive shares from stock options, restricted stock units, warrants and Convertible Notes were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented. Therefore, basic and diluted EPS are computed using the same number of weighted-average shares for the three months ended March 31, 2024 and 2023.
The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:

Three Months Ended March 31,
2024
2023
Stock options and restricted stock units9,048,602 6,987,945 
Warrants
61,411,393 7,326,654 
Convertible Notes
16,226,124 16,950,606 
27

Table of Contents
EOS ENERGY ENTERPRISES, INC.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
19. Subsequent Events
On April 22, 2024, the Company closed an agreement with Banyan Software, Inc. to accelerate its 2023 Production Tax Credit monetization. The Company received $2,303 in cash. This amount relates to a portion of the PTC grant receivable as of March 31, 2024, as discussed in Note 10, Government Grants.

28

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the accompanying Unaudited Condensed Consolidated Financial Statements for the three months ended March 31, 2024 and 2023 and the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, including the financial statements and notes thereto.
Overview
The Company offers an innovative Znyth™ technology battery energy storage system ("BESS") designed to provide the operating flexibility to manage increased grid complexity and price volatility resulting from an overall increase in renewable energy generation and a congested grid coming from an increase in electricity demand growth. The Company’s BESS is a validated chemistry with accessible non-precious earth components in a durable design that is intended to deliver results in even the most extreme temperatures and conditions. The system is designed to be safe, flexible, scalable, sustainable and manufactured in the United States using raw materials primarily sourced in the United States. We believe the Company’s Z3™ battery module is the core of its innovative systems. The Z3 battery module is the only US designed and manufactured battery module that today provide utilities, independent power producers, renewables developers and C&I customers with an alternative to lithium-ion and lead-acid monopolar batteries for critical 3- to 12-hour discharge duration applications. We believe the Z3 battery will transform how utility, industrial and commercial customers store power.
In addition to its BESS, the Company currently offers: (a) a BMS which provides a remote asset monitoring capability and service to track the performance and health of the Company’s BESS and to proactively identify future system performance issues through predictive analytics; (b) project management services to ensure the process of implementing the Company’s BESS are coordinated in conjunction with the customer’s overall project plans; (c) commissioning services that ensure the customer’s installation of the BESS meets the performance expected by the customer; and (d) long-term maintenance plans to maintain optimal operating performance of the Company’s systems.
The Company’s growth strategy contemplates increasing sales of battery energy storage systems and related software and services through a direct sales team and sales channel partners. The Company’s current and target customers include utilities, project developers, independent power producers and commercial and industrial companies.
Strategy
The Company continues to invest in the refinement and production of its Z3 battery, which builds off the same electrochemistry that has not fundamentally changed for the better part of a decade. The next Z3 battery is designed to reduce cost and weight while improving manufacturability and system performance. The Eos Z3 battery is more cost-effective and has a simpler tub design with 50% fewer cells and 98% fewer welds per battery module than the Gen 2.3. The Company currently expects that the Z3 battery will give customers the benefit of two times the energy density per square foot with the same safety and reliability. The Z3 transition is fully underway and the first semi-automated battery manufacturing line is installed and has started commercial production. The Z3 batteries utilize the same chemistry, which has over 3 million cycles, and incorporate a new mechanical design aimed at improving performance, lowering cost and increasing manufacturability.
The Company started delivery of its Z3 battery modules in the third quarter of 2023. The Z3 battery incorporates valuable lessons learned from the past 15 years into a new system design which the Company expects to result in efficiencies as it develops its new state-of-the-art manufacturing line.
The Company believes the simplicity, flexibility and safety of our products are what the market desires. In addition, we believe that the Inflation Reduction Act gives us a competitive advantage by virtue of production tax credits (“PTC”) that can be claimed on battery components manufactured domestically, and tax credits for customers for projects that satisfy domestic content requirements. See Regulatory Landscape section. The Company intends to engage with a consortium of community leaders, universities and supply chain partners in anticipation of pursuing grants made available under the Bipartisan Infrastructure Law of 2021.
29

Regulatory Landscape
U.S. Department of Energy (“DOE”)
In August 2023, the DOE issued a Conditional Commitment Letter to the Company for a loan of an aggregate principal amount of up to $398.6 million through the DOE’s Clean Energy Financing Program. The Conditional Commitment Letter follows an extensive technical, financial and commercial due diligence process by the DOE. If finalized, the loan is expected to fund 80% of eligible costs of the Company’s planned manufacturing expansion in Turtle Creek, Pennsylvania.
Eligible costs include capital expenditures and other costs associated with ramping up the manufacturing lines and facility, for example start-up and shakedown costs, as well as certain material and labor costs before efficiencies are met. The Company is working to finalize the loan documents with the DOE and to fulfill certain conditions precedent. Eos is spending eligible costs now that would be reimbursable at first funding.
Inflation Reduction Act of 2022 (“IRA”)
The IRA features significant economic incentives for both energy storage customers and manufacturers for projects placed in service after December 31, 2022. One of the most important features of the IRA is that it offers a 10-year term tax credit, whereas historically similar industrial credits have been shorter in duration. Customers placing new energy storage facilities in service will be allowed to claim at least a thirty percent investment tax credit (“ITC”) under certain conditions. The IRA also offers an extra ten percent credit if the project is in an “energy community” and another ten percent credit if the project satisfies domestic content requirements, which will be set forth when the implementing regulations are finalized. The ten percent bonus for domestic content could represent a strategic advantage for the Company resulting from the Company’s near-sourcing and Made in America strategy, and we currently anticipate that projects utilizing Eos batteries will qualify for the bonus.
As discussed in Note 10, Government Grants to our Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report, starting in 2023, there are Production Tax Credits under Internal Revenue Code 45X (“PTC”) that can be claimed on battery components manufactured in the U.S. and sold to U.S. or foreign customers. These tax credits available to manufacturers include a credit for ten percent of the cost incurred to make electrode active materials in addition to credits of $35 per kWh of capacity of battery cells and $10 per kWh of capacity of battery modules. These credits are cumulative, meaning that companies will be able to claim each of the available tax credits based on the battery components produced and sold through 2029, after which the PTC will begin to gradually phase down through 2032. These credits are expected to be a new source of cash flow for Eos in the future.
Company Highlights
In January 2024, the Company entered into a supply agreement with TETRA Technologies, Inc (“TETRA”) that further expanded this partnership. TETRA is a leading global energy services and solutions company. This supply agreement designates TETRA as the preferred strategic supplier of electrolyte products for the Company’s Eos Z3TM long duration energy storage cube.
In February 2024, the Company entered into a multiyear pricing agreement with SHPP US LLC, a Saudi Basic Industries Corporation (“SABIC”) affiliate, to supply conductive composite thermoplastic for the Eos Z3TM battery module. The Company and SABIC have worked collaboratively to develop a solution using one of SABIC’s new resin materials to replace the titanium used in prior Eos battery iterations.
In February 2024, the Company achieved “Power On” status of all motion systems on its first state-of-the-art manufacturing line. Reaching this milestone is a significant step in achieving the state-of-the-art manufacturing line being installed and commissioned in the Company’s Turtle Creek facility.
For the three months ended March 31, 2024, the Company recognized $1.5 million of grant income related to the IRA PTC.

30

Results of Operations
Revenue
For the Three Months Ended March 31,
($ in thousands)
2024
2023
$ Change% Change
Revenue$6,601 $8,835 (2,234)(25)%
The Company generates revenues from the delivery of its battery energy storage systems (“BESS”) and service-related solutions. The Company expects revenues to increase as it scales production to meet customer demand.
Revenue decreased by $2.2 million, or 25% from $8.8 million for the three months ended March 31, 2023 to $6.6 million for the three months ended March 31, 2024. The reduction in revenues for the three months ended March 31, 2024 was due to reduced production and deliveries in view of the Company’s shift to next generation Eos Z3TM technology.
Cost of goods sold
For the Three Months Ended March 31,
($ in thousands)
2024
2023
$ Change% Change
Cost of goods sold$28,229 $26,940 1,289 %
Cost of goods sold primarily consists of direct costs relating to labor, material and overhead directly tied to product manufacturing, engineering, procurement and construction (“EPC”), project delivery, commissioning and start-up test procedures. Indirect costs included in cost of goods sold are manufacturing overhead such as manufacturing engineering, equipment maintenance, environmental health and safety, quality and production control procurement, transportation, logistics, depreciation and facility-related costs. As a nascent technology with a new manufacturing process that is early in its product lifecycle, the Company still faces significant costs associated with production start-up, commissioning of various components, modules and subsystems and other related costs. The Company expects its cost of goods sold to exceed revenues in the near term as it continues to scale production and prepares battery energy storage systems delivered to customers to go-live.
Cost of goods sold increased by $1.3 million, or 5% from $26.9 million for the three months ended March 31, 2023 to $28.2 million for the three months ended March 31, 2024. The increase was primarily due to higher volume of cubes produced and shipped during the three months ended March 31, 2024 compared to the three months ended March 31, 2023.
Research and development expenses
For the Three Months Ended March 31,
($ in thousands)
2024
2023
$ Change% Change
R&D expenses$5,200 $5,445 (245)(4)%
Research and development expenses consist primarily of salaries and other personnel-related costs, materials, third-party services, depreciation and amortization of intangible assets.
Research and development costs decreased by $0.2 million or 4% from $5.4 million for the three months ended March 31, 2023 to $5.2 million for the three months ended March 31, 2024. The decrease was driven by lower spending on materials and supplies, partially offset by an increase in payroll and personnel costs and stock compensation costs.
31

Selling, general and administrative expenses
For the Three Months Ended March 31,
($ in thousands)
2024
2023
$ Change% Change
SG&A expenses$14,242 $13,955 287 %
Selling, general and administrative expenses primarily consist of payroll and personnel-related, outside professional services, facilities, depreciation, travel, marketing and public company costs.
Selling, general and administrative expenses increased by $0.3 million or 2% from $14.0 million for the three months ended March 31, 2023 to $14.2 million for the three months ended March 31, 2024. The slight increase was driven by increases in payroll, personnel costs and facility costs, partially offset by lower stock compensation costs.
Loss from write-down of property, plant and equipment
For the Three Months Ended March 31,
($ in thousands)
2024
2023
Loss from write-down of property, plant and equipment$65 $760 
The Company incurred a loss of $0.1 million and $0.8 million from write-down of property, plant and equipment for the three months ended March 31, 2024 and 2023, respectively, due to write-offs for disposal of equipment and tooling that was used to manufacture the Gen 2.3 BESS, but cannot be repurposed for the next generation Eos Z3 battery.
Interest expense, net
For the Three Months Ended March 31,
($ in thousands)
2024
2023
Interest expense, net$(4,267)$(4,829)
Interest expense, net includes expenses for accrued interest, amortization of debt issuance costs and debt discounts, partially offset by capitalized interest costs on CIP assets (see Note 6, Property, Plant and Equipment for further discussion). Interest expense, net decreased slightly by $0.6 million for the three months ended March 31, 2024, primarily due to the capitalized interest on CIP assets recognized in 2024, offset by increased interest expense recognized from the Senior Secured Term Loan.
Interest expense - related party
For the Three Months Ended March 31,
($ in thousands)20242023
2021 Convertible Note Payable interest and amortization
$(3,416)$(2,961)
AFG Convertible Note interest and amortization
(1,435)(969)
AFG Convertible Note Day 1 loss
— (2,873)
Yorkville Promissory Notes Day 1 losses
— (6,952)
     Interest expense, related party
$(4,851)$(13,755)
See Note 12, Borrowings to our Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report for further discussion.
32

Change in fair value of warrants
The change in fair value of warrants is composed of the following:
For the Three Months Ended March 31,
20242023
IPO warrants$$(156)
April 2023 warrants
782 — 
May 2023 warrants
186 — 
December 2023 warrants
1926 — 
     Change in fair value of warrants$2,900 $(156)
Change in fair value of derivatives - related parties
For the Three Months Ended March 31,
($ in thousands)
2024
2023
Change in fair value of derivatives - related parties
$534 $(12,934)
The change in the fair value of derivatives - related parties, is due to changes in fair value of the embedded derivatives in our convertible debt (See Note 12, Borrowings) for the three months ended March 31, 2024, compared to the three months ended March 31, 2023. The change was largely a result of the change in the Company's stock price.
Loss on debt extinguishment
For the Three Months Ended March 31,
($ in thousands)
2024
2023
Loss on debt extinguishment$— $(1,634)
The Company recognized a loss on debt extinguishment of $1.6 million for the three months ended March 31, 2023 from the issuance of common stock upon Yorkville's redemption of their Convertible Promissory Notes.
Other income (expense)
For the Three Months Ended March 31,
($ in thousands)
2024
2023
Other income (expense)
$136 $(17)
Other income (expense) slightly increased by $0.2 million for the three months ended March 31, 2024, compared to the three months ended March 31, 2023.
For the Three Months Ended March 31,
($ in thousands)
2024
2023
Income tax expense
$25 $10 
The Company incurred income tax expense for the three months ended March 31, 2024 and 2023 in relation to the pre-tax income from the Company’s international subsidiaries.
33

Liquidity and Capital Resources
Liquidity and Going Concern
As a growth company in the early commercialization stage of its lifecycle, Eos is subject to inherent risks and uncertainties associated with the development of an enterprise. In this regard, substantially all of the Company’s efforts to date have been devoted to the development and manufacturing of battery energy storage systems and complimentary products and services, recruitment of management and technical staff, deployment of capital to expand the Company’s operations to meet customer demand and raising capital to fund the Company’s development. As a result of these efforts, the Company has incurred significant losses and negative cash flows from operations since its inception and expects to continue to incur such losses and negative cash flows for the foreseeable future until such time that the Company can reach a scale of profitability to sustain its operations.
In order to execute its development strategy, the Company has historically relied on outside capital through the issuance of equity, debt and borrowings under financing arrangements (collectively “outside capital”) to fund its cost structure and expects to continue to rely on outside capital for the foreseeable future. While the Company believes it will eventually reach a scale of profitability to sustain its operations, there can be no assurance the Company will be able to achieve such profitability or do so in a manner that does not require its continued reliance on outside capital. Moreover, while the Company has historically been successful in raising outside capital, there can be no assurance the Company will be able to continue to obtain outside capital in the future or do so on terms that are acceptable to the Company.
As of the date the accompanying Condensed Consolidated Financial Statements were issued (the “issuance date”), management evaluated the significance of the following negative financial conditions in accordance with Accounting Standard Codification 205-40, Going Concern:
Since its inception, the Company has incurred significant losses and negative cash from operations in order to fund its development. During the three months ended March 31, 2024, the Company incurred a net loss of $46.7 million, incurred negative cash flows from operations of $40.5 million and had an accumulated deficit of $922.6 million as of March 31, 2024.
As of March 31, 2024, the Company had $31.8 million of unrestricted cash and cash equivalents available to fund the Company’s operations and working capital of $22.1 million, inclusive of $3.5 million of outstanding debt that is currently scheduled to mature within the next twelve months. Additionally, the Company has no additional borrowings available under pre-existing financing arrangements to fund its operations (see Note 12, Borrowings).
The Company has available capacity under its ATM offering program to issue shares of the Company’s common stock, (see also Note 18, Shareholders’ Deficit) to aid in funding the Company’s operations. However, the Company’s ability to secure such funding is dependent upon certain conditions, such as investors’ willingness to purchase the Company’s common stock and at a price that is acceptable to the Company. Accordingly, as of the issuance date, there is no assurance the Company will be able to secure funding under these pre-existing arrangements or on terms that are acceptable to the Company.
Similarly, while the Company has historically been successful in raising additional outside capital to fund the Company’s operations, as of the issuance date no assurance can be provided the Company will be successful in obtaining additional outside capital or on terms that are acceptable to the Company. In this regard, the Company continues to progress through the Department of Energy (“DOE”) Loan Programs Office’s (“LPO”) process for its Title XVII loan. In August 2023, the DOE issued a conditional commitment letter to the Company for a loan of an aggregate principal amount of up to $398.6 million through the DOE’s Clean Energy Financing Program. Certain technical, legal and financial conditions must be met and due diligence to the satisfaction of the DOE must be completed before the DOE enters into definitive financing documents with the Company and funds the loan. There can be no assurance that the Company will be able to secure such a loan or on terms that are acceptable to the Company.
34

The Company is required to remain in compliance with a quarterly minimum financial liquidity covenant under its Senior Secured Term Loan Credit Agreement (“Senior Secured Term Loan”). While the Company was in compliance with this covenant as of March 31, 2024, the Company expects it may be unable to remain in compliance with this covenant beginning on June 30, 2024 and thereafter absent the Company’s ability to secure a waiver or raise additional outside capital. In the event the Company is unable to remain in compliance with the minimum financial liquidity covenant and the other nonfinancial covenants required by the Senior Secured Term Loan and the Company is further unable to cure such noncompliance or secure a waiver, Lender - Atlas Credit Partners (ACP) Post Oak Credit I LLC (“Atlas”) may, at its discretion, exercise any and all of its existing rights and remedies, which may include, among other things, entering into a forbearance agreement with the Company and/or asserting its rights in the Company’s assets securing the loan. Moreover, the Company’s other lenders may exercise similar rights and remedies under the cross-default provisions of their respective borrowing arrangements with the Company.
Absent an ability to secure additional outside capital in the near term, the Company will be unable to meet its obligations as they become due over the next twelve months beyond the issuance date.
In the event the Company’s ongoing efforts to raise additional outside capital prove unsuccessful, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors and/or allowing the Company to become insolvent.
These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying Unaudited Condensed Consolidated Financial Statements do not include any adjustments that may result from the outcome of these uncertainties.
Financing Arrangements
The Company has historically relied on outside capital to fund its cost structure and expects this reliance to continue for the foreseeable future until the Company reaches profitability through its planned revenue generating activities. During the three months ended March 31, 2024, the Company closed on the following capital transactions:
Under the ATM offering program, for the three months ended March 31, 2024, the Company sold 7,239,982 shares raising proceeds of $7.2 million, net of fees paid to Cowen, at an average selling price of $1.03 per share, included in the Condensed Consolidated Statement of Shareholders' Deficit.
Capital Expenditures
The Company expects capital expenditures and working capital requirements to increase as it executes its growth strategy. Total capital expenditures for the three months ended March 31, 2024 and March 31, 2023 were $4.0 million and $2.9 million, respectively. The increase in capital expenditures in 2024 was primarily driven by costs incurred for development and construction of a fully automated manufacturing line that will be used for the Z3 battery in 2024 and years thereafter. These costs are classified as Construction in Progress (see Note 6, Property, Plant and Equipment for further discussion).
Discussion and Analysis of Cash Flows
The Company relies heavily on private placement of convertible notes, term loans, equipment financing and issuance of common stock and warrants. Our short-term working capital needs are primarily related to funding of debt interest payments, repayment of debt principal, product manufacturing, research and development and general corporate expenses. The Company’s long-term working capital needs are primarily related to repayment of long-term debt obligations and capital expenses for capacity expansion and maintenance, equipment upgrades and repair of equipment.
The following table summarizes the Company’s cash flows from operating, investing and financing activities for the periods presented.
 
Three Months Ended March 31,
($ in thousands)20242023$ Change
Net cash used in operating activities$(40,474)$(30,478)$(9,996)
Net cash used in investing activities$(4,042)$(2,897)$(1,145)
Net cash provided by financing activities$6,111 $32,455 $(26,344)
35

Cash flows from operating activities:
Cash flows used in operating activities primarily comprise of costs related to research and development, manufacturing of products, project commissioning and other general and administrative activities.
Net cash used in operating activities of $40.5 million for the three months ended March 31, 2024 was primarily driven by a net loss of $46.7 million, adjusted for non-cash items of $3.5 million, primarily related to stock compensation expense, depreciation and amortization, non-cash interest expense and changes in fair value of warrants and derivatives. The net cash inflows from changes in operating assets and liabilities was $2.7 million, primarily driven by increase in accrued expenses of $6.2 million, increase in interest payable of $2.9 million, decrease in inventory of $2.7 million, partially offset by increase in contract assets of $4.6 million, decrease in accounts payable of $2.6 million and increase in grant receivable of $1.5 million.
Net cash used in operating activities was $30.5 million for the three months ended March 31, 2023, primarily driven by a net loss of $71.6 million, adjusted for non-cash items of $34.0 million, primarily related to stock compensation expense, depreciation and amortization, non-cash interest expense, changes in fair value of warrants and derivatives and loss from the write-down of property, plant and equipment. The net cash inflows from changes in operating assets and liabilities was $7.1 million, primarily driven by a decrease in inventory of $9.2 million, increase in accounts payable and accrued expenses of $4.8 million and increase in interest payable of $2.4 million, offset by decrease in contract liabilities of $3.5 million, increase in accounts receivable of $2.0 million and increase in contract assets of $1.9 million.
Cash flows from investing activities:
Net cash flows used in investing activities for the three months ended March 31, 2024 were composed of payments made for purchases of property, plant and equipment of $4.0 million.
Net cash flows used in investing activities for the three months ended March 31, 2023 were primarily composed of payments made for purchases of property, plant and equipment of $2.9 million.
Cash flows from financing activities:
Net cash provided by financing activities was $6.1 million for the three months ended March 31, 2024, primarily due to the issuance of common stock of $7.2 million. The proceeds were partially offset by payments on the equipment financing facility of $0.8 million and share repurchases from employees for tax withholding purposes of $0.3 million.
Net cash provided by financing activities was $32.5 million for the three months ended March 31, 2023, primarily due to the net proceeds received from the Yorkville Convertible Promissory Notes and AFG Convertible Notes of $33.4 million and the issuance of common stock of $1.3 million. The proceeds were partially offset by debt issuance costs related to the Yorkville Convertible Promissory Notes and AFG Convertible Notes of $1.1 million, payments on the equipment financing facility of $0.7 million and share repurchases from employees for tax withholding purposes of $0.3 million.
Contractual Obligations
The Company has certain obligations and commitments to make future payments under contracts. As of March 31, 2024, this is composed of the following:
Future lease payments, including interest, under non-cancellable operating and financing leases of $5.6 million. The leases expire at various dates prior to 2028. See Note 15, Commitments and Contingencies to our Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report.
Principal and Interest payments related to the following debt obligations (see Note 12, Borrowings to our Unaudited Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report):
Future Debt Payments
2021 Convertible Note Payable - due June 2026 (1)
$134,261 
AFG Convertible Notes - due June 2026 (1)
32,468 
Senior Secured Term Loan - due March 2026128,300 
Equipment financing facility - due April 2025 and April 2026
5,583 
  Total $300,612 
(1) As of March 31, 2024, the Company is obligated to repay future contractual interest payments for the 2021 Convertible Note and AFG Convertible Notes in-kind.
36

Critical Accounting Estimates
The Company’s Unaudited Condensed Consolidated Financial Statements are prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP). In preparing the Company’s Unaudited Condensed Consolidated Financial Statements, management makes assumptions, judgments and estimates on historical experience and various other factors that management believes to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. Management regularly reevaluates assumptions, judgments and estimates. The Company’s significant accounting policies are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
There have been no material changes to the Company’s critical accounting estimates for the three months ended March 31, 2024, as compared to those discussed in its Annual Report on Form 10-K for the year ended December 31, 2023.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in the Company’s market risk exposures for the three months ended March 31, 2024, as compared to those discussed in its Annual Report on Form 10-K for the year ended December 31, 2023.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s management, under the supervision of the Chief Executive Officer (CEO) and the Chief Financial Officer (CFO), evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation and consistent with the evaluations previously reported in prior periods, the CEO and CFO have concluded that the Company’s disclosure controls and procedures were not effective as of March 31, 2024 because of material weaknesses resulting from lack of a formalized internal control framework in accordance with the Committee of Sponsoring Organizations (COSO) Framework, inadequate segregation of duties in the financial reporting process, lack of review and approval of journal entries and a lack of management review controls.
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in the Company’s reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in the Company’s reports filed under the Exchange Act is accumulated and communicated to management, including its CEO and its CFO, to allow timely decisions regarding required disclosure.
In light of these material weaknesses, management performed additional analyses, reconciliations and other post-closing procedures to determine that the Company’s Unaudited Condensed Consolidated Financial Statements are prepared in accordance with U.S. GAAP. Based on this review, management concluded that the Unaudited Condensed Consolidated Financial Statements included in this report fairly present in all material respects the Company’s financial condition, results of operations and cash flows for the periods presented.
Management’s Remediation Plan
In response to the material weaknesses, management, with oversight from the Audit Committee has identified and begun to implement steps to remediate the material weaknesses. These remediation efforts are detailed in Item 9A,“Controls and Procedures” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
Changes in Internal Control Over Financial Reporting
Other than the actions taken as described in Management's Remediation Plan above to improve the Company’s internal control over financial reporting, there have been no changes in our internal control over financial reporting during the quarter ended March 31, 2024 that materially affected, or which are reasonably likely to materially affect, our internal control over financial reporting.
Part II - Other information
Item 1. Legal Proceedings
37

From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations. While the outcomes of these types of claims are uncertain, management does not expect that the ultimate costs to resolve these matters will have a material adverse effect on our consolidated financial position, results of operations or cash flows.
The following is also disclosed in Note 15, Commitments and Contingencies to our Unaudited Condensed Consolidated Financial Statements:
Class Action Complaints
On March 8, 2023, a class action lawsuit was filed in the Court of Chancery of the State of Delaware by plaintiff Richard Delman against certain defendants including the Company’s former directors (the “Delman Defendants”). Neither the Company nor Eos Energy Storage LLC were named as a defendant but each was identified in the Complaint as a relevant non-party and the Company has indemnification obligations relating to the lawsuit. On February 1, 2024, the parties agreed to a binding Settlement Term Sheet (the “Settlement”) whereby plaintiff agreed to resolve the lawsuit in exchange for a settlement payment of $8,500, consisting of cash payments previously made by the Company of approximately $1,000 and an additional cash payment of approximately $7,500 funded by the Company’s Directors and Officers (“D&O”) liability insurance policies. The definitive settlement agreement is currently being negotiated between the parties. Once finalized, the settlement agreement will be submitted to the Court of Chancery for final approval.
On August 1, 2023, a class action lawsuit was filed in the United States District Court of New Jersey by plaintiff William Houck against the Company, the Company’s Chief Executive Officer, its former Chief Financial Officer and its current Chief Financial Officer (with the Company, the “Houck Defendants”). The Complaint alleges that the defendants violated federal securities laws by making knowingly false or misleading statements about the Company’s contractual relationship with a customer and about the size of the Company’s order backlog and commercial pipeline. Defendants deny the allegations and, on February 13, 2024, moved to dismiss the Complaint. On March 5, 2024, plaintiff filed an amended complaint that dropped the Company’s former Chief Financial Officer as a defendant. On April 4, 2024, defendants filed a renewed motion to dismiss the lawsuit. The Company intends to continue to vigorously defend against this action.
Item 1A. Risk Factors
As of the date of this Quarterly Report on Form 10-Q, there have been no additional material changes to the risk factors disclosed in our annual report on Form 10-K for the fiscal year ended December 31, 2023. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
None
38

(a) Exhibits
Incorporated by Reference
Exhibit NumberDescription of DocumentSchedule/FormFile NumberExhibitsFiling Date
3.1Form 10-KFile No. 001-392913.1February 28, 2023
3.2*
3.3Form 8-KFile No. 001-392913.1May 19, 2022
10.1Form 8-KFile No. 001-3929110.10November 20, 2020
10.2†
Form 8-KFile No. 001-3929110.1January 9, 2024
10.3†
Form 8-KFile No. 001-3929110.1February 1, 2024
10.4
Form S-8
File No. 001-3929199.2June 17, 2022
10.5
Form S-8
File No. 001-3929199.3June 23, 2023
10.6*
31.1*
31.2*
32*
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
39

Incorporated by Reference
Exhibit NumberDescription of DocumentSchedule/FormFile NumberExhibitsFiling Date
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104
Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
____________________________
Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5) and certain confidential portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. These redacted terms have been marked in this exhibit at the appropriate place with three asterisks. The Registrant agrees to furnish an unredacted copy and a copy of all omitted exhibits and schedules to the SEC upon its request.
*Filed herewith.
40

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
EOS ENERGY ENTERPRISES, INC.
Date: May 14, 2024
By:/s/ Joseph Mastrangelo
Name:Joseph Mastrangelo
Title:Chief Executive Officer and Director
(Principal Executive Officer)
Date: May 14, 2024
By:/s/ Nathan Kroeker
Name:Nathan Kroeker
Title:
Chief Financial Officer
(Principal Financial Officer)

41
EOS ENERGY ENTERPRISES, INC. Second Certificate of Amendment to The Third Amended and Restated Certificate of Incorporation FIRST: The present name of the corporation is Eos Energy Enterprises, Inc., a Delaware corporation (the “Corporation”). The original certificate of incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on June 3, 2019. An Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on February 4, 2020. A Second Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on May 19, 2020. A Third Amended and Restated Certificate of Incorporation (the “Third Amended and Restated Certificate”) was filed with the Secretary of State of the State of Delaware on November 16, 2020. A certificate of amendment to the Third Amended and Restated Certificate was filed with the Secretary of State of the State of Delaware on June 28, 2022. SECOND: Section 4.1(b) of Article IV of the Company’s Third Amended and Restated Certificate is hereby amended to read in its entirety as set forth below: (b) The total number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Corporation is authorized to issue is 601,000,000 shares, consisting of (a) 600,000,000 shares of common stock (the “Common Stock”) and (b) 1,000,000 shares of preferred stock (the “Preferred Stock”). THIRD: The foregoing amendment has been duly proposed and declared advisable by the Corporation’s Board of Directors and adopted by the Corporation’s stockholders in accordance with the provisions of Sections 222 and 242 of the General Corporation Law of the State of Delaware. FOURTH: This Second Certificate of Amendment shall become effective as of upon the filing of this Second Certificate of Amendment with the Secretary of State of the State of Delaware. * * * * * IN WITNESS WHEREOF, the Corporation has caused this Second Certificate of Amendment to be signed by an authorized officer of the Corporation this 8th day of May, 2024. Eos Energy Enterprises, Inc. By: /s/Michael W. Silberman Michael Silberman General Counsel and Corporate Secretary


 
Third Amendment to the Eos Energy Enterprises, Inc. Amended and Restated 2020 Incentive Plan This Third Amendment (this “Amendment”) to the Eos Energy Enterprises, Inc. Amended and Restated 2020 Incentive Plan (as amended, restated, replaced, supplemented, or otherwise modified from time to time, the “Plan”) is approved and adopted to be effective as of May 1, 2024 (the “Effective Date”). Background A. The Plan was previously amended pursuant to the First Amendment to the Plan, dated as of May 17, 2022, and the Second Amendment to the Plan, dated as of May 16, 2023. B. On the Effective Date, the stockholders of Eos Energy Enterprises, Inc., a Delaware corporation (the “Company”) approved this Amendment. C. The Company now desires to amend the Plan in accordance with the terms and conditions of this Amendment. Terms and Conditions NOW THEREFORE, effective as of the Effective Date, the terms and conditions of the Plan are amended as follows: 1. Sections 5(b) of the Plan is hereby deleted in its entirety and replaced with the following: 5. Grant of Awards; Shares Subject to the Plan; Limitations. (b) Subject to Section 12 of the Plan and this Section 5, Awards granted under the Plan shall be subject to the following limitations: (i) the Committee is authorized to deliver under the Plan an aggregate of 23,935,317 Common Stock; provided, that the maximum number of Common Stock that may be granted under the Plan during any single fiscal year to any Participant who is a non-employee director, when taken together with any cash fees paid to such nonemployee director during such year in respect of his service as a non-employee director (including service as a member or chair of any committee of the Board), shall not exceed $500,000 in total value (calculating the value of any such Awards based on the Fair Market Value on the Date of Grant of such Awards for financial reporting purposes); provided that the non-employee directors who are considered independent (under the rules of The Nasdaq Capital Market or other securities exchange on which the Common Stock is traded) may make exceptions to this limit for a non-executive chair of the Board, if any, in which case the non-employee director receiving such additional compensation may not participate in the decision to award such compensation.


 
Third Amendment to the Eos Energy Enterprises, Inc. May 1, 2024 Amended and Restated 2020 Incentive Plan __________________________________________________________________________________ Page 2 2. Sections 7(a) of the Plan is hereby deleted in its entirety and replaced with the following: 7. Options. (a) Generally. Each Option granted under the Plan shall be evidenced by an Award Agreement (whether in paper or electronic medium (including email or the posting on a web site maintained by the Company or a third party under contract with the Company)). Each Option so granted shall be subject to the conditions set forth in this Section 7 and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. All Options granted under the Plan shall be Nonqualified Stock Options unless the applicable Award Agreement expressly states that the Option is intended to be an Incentive Stock Option. Subject to Section 12, the maximum aggregate number of Common Stock that may be issued through the exercise of Incentive Stock Options granted under the Plan is 23,935,317 Common Stock. Incentive Stock Options shall be granted only to Eligible Persons who are employees of the Company and its Affiliates, and no Incentive Stock Option shall be granted to any Eligible Person who is ineligible to receive an Incentive Stock Option under the Code. No Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the stockholder of the Company in a manner intended to comply with the stockholder approval requirements of Section 422(b)(1) of the Code; provided that any Option intended to be an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain such approval, but rather such Option shall be treated as a Nonqualified Stock Option unless and until such approval is obtained. In the case of an Incentive Stock Option, the terms and conditions of such grant shall be subject to and comply with such rules as may be prescribed by Section 422 of the Code. If for any reason an Option intended to be an Incentive Stock Option (or any portion thereof) shall not qualify as an Incentive Stock Option, then, to the extent of such nonqualification, such Option or portion thereof shall be regarded as a Nonqualified Stock Option appropriately granted under the Plan. 3. Incorporation: This Amendment shall be deemed as amending and incorporated into the Plan. All of the terms, conditions, and provisions of the Plan shall continue unchanged and remain in full force and effect except as expressly amended by this Amendment. IN WITNESS WHEREOF, the Company hereby executes this Amendment as of the Effective Date. Eos Energy Enterprises, Inc. By: /s/Michael W. Silberman Michael Silberman General Counsel and Corporate Secretary


 


EXHIBIT 31.1
CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF
THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph Mastrangelo, certify that:
1. I have reviewed this quarterly report on Form 10-Q (the “Report”) of Eos Energy Enterprises, Inc. (the “Registrant”);
2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;
3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and
d. Disclosed in this Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: May 14, 2024
By:/s/ Joseph Mastrangelo
Joseph Mastrangelo
Chief Executive Officer
(Principal Executive Officer)

    


EXHIBIT 31.2
CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF
THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Nathan Kroeker, certify that:
1. I have reviewed this quarterly report on Form 10-Q (the “Report”) of Eos Energy Enterprises, Inc. (the Registrant”);
2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;
3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and
d. Disclosed in this Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: May 14, 2024
By:/s/ Nathan Kroeker
Nathan Kroeker
Chief Financial Officer
(Principal Financial Officer)


    


EXHIBIT 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Eos Energy Enterprises, Inc. (the “Registrant”), for the quarterly period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph Mastrangelo, hereby certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date: May 14, 2024
By:/s/ Joseph Mastrangelo
Joseph Mastrangelo
Chief Executive Officer
(Principal Executive Officer)

In connection with the Quarterly Report on Form 10-Q of Eos Energy Enterprises, Inc. (the “Registrant”), for the quarterly period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Nathan Kroeker, hereby certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date: May 14, 2024
By:/s/ Nathan Kroeker
Nathan Kroeker
Chief Financial Officer
(Principal Financial Officer)

    
v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 08, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-39291  
Entity Registrant Name EOS ENERGY ENTERPRISES, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 84-4290188  
Entity Address, Address Line One 3920 Park Avenue  
Entity Address, City or Town Edison  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 08820  
City Area Code 732  
Local Phone Number 225-8400  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   208,127,550
Entity Central Index Key 0001805077  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Common Stock    
Document Information [Line Items]    
Title of 12(b) Security Common stock, par value $0.0001 per share  
Trading Symbol EOSE  
Security Exchange Name NASDAQ  
Warrants    
Document Information [Line Items]    
Title of 12(b) Security Warrants, each exercisable for one share of common stock  
Trading Symbol EOSEW  
Security Exchange Name NASDAQ  
v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 31,773 $ 69,473
Restricted cash 2,625 3,439
Accounts receivable, net 3,953 3,387
Inventory, net 14,393 17,070
Vendor deposits 6,513 7,161
Contract assets, current 11,075 6,386
Prepaid expenses 1,278 1,082
Grant receivable 4,798 3,256
Other receivables 7,500 7,500
Other current assets 3,110 3,577
Total current assets 87,018 122,331
Property, plant and equipment, net 42,742 37,855
Intangible assets, net 282 295
Goodwill 4,331 4,331
Operating lease right-of-use asset, net 3,735 4,033
Long-term restricted cash 11,858 11,755
Other assets, net 5,716 5,892
Total assets 155,682 186,492
Current liabilities:    
Accounts payable 18,339 20,540
Accrued expenses 38,614 32,332
Operating lease liability, current 1,574 1,496
Long-term debt, current 3,458 3,332
Contract liabilities, current 2,828 3,070
Other current liabilities 108 100
Total current liabilities 64,921 60,870
Long-term liabilities:    
Operating lease liability 2,922 3,350
Long-term debt 88,222 88,002
Convertible notes payable - related party 113,950 112,525
Interest payable - related party 2,892 0
Contract liabilities, long-term 4,283 3,540
Warrants liability 24,561 27,461
Other liabilities 1,604 1,544
Total long-term liabilities 238,434 236,422
Total liabilities 303,355 297,292
COMMITMENTS AND CONTINGENCIES (NOTE 15)
SHAREHOLDERS' DEFICIT    
Common stock, $0.0001 par value, 300,000,000 shares authorized, 206,779,447 and 199,133,827 shares outstanding on March 31, 2024 and December 31, 2023, respectively 22 21
Preferred stock, $0.0001 par value, 1,000,000 shares authorized, no shares outstanding on March 31, 2024 and December 31, 2023 0 0
Additional paid in capital 774,857 765,018
Accumulated deficit (922,554) (875,846)
Accumulated other comprehensive income 2 7
Total shareholders' deficit (147,673) (110,800)
Total liabilities and shareholders' deficit $ 155,682 $ 186,492
v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 300,000,000 300,000,000
Common stock, shares issued (in shares) 206,779,447 199,133,827
Common stock, shares outstanding (in shares) 206,779,447 199,133,827
Preferred stock issued per unit (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 1,000,000 1,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue    
Total revenue $ 6,601 $ 8,835
Costs and expenses    
Cost of goods sold 28,229 26,940
Research and development expenses 5,200 5,445
Selling, general and administrative expenses 14,242 13,955
Loss from write-down of property, plant and equipment 65 760
Total costs and expenses 47,736 47,100
Operating loss (41,135) (38,265)
Other (expense) income    
Change in fair value of warrants 2,900 (156)
Change in fair value of derivatives - related parties 534 (12,934)
Loss on debt extinguishment 0 (1,634)
Other income (expense) 136 (17)
Loss before income taxes (46,683) (71,590)
Income tax expense 25 10
Net loss (46,708) (71,600)
Other comprehensive income    
Foreign currency translation adjustment, net of tax (5) 1
Comprehensive loss $ (46,713) $ (71,599)
Basic and diluted loss per share attributable to common shareholders    
Basic (in dollars per share) $ (0.23) $ (0.82)
Diluted (in dollars per share) $ (0.23) $ (0.82)
Weighted average shares of common stock    
Basic (in shares) 201,306,905 86,797,669
Diluted (in shares) 201,306,905 86,797,669
Nonrelated Party    
Other (expense) income    
Interest expense, net $ (4,267) $ (4,829)
Related Party    
Other (expense) income    
Interest expense, net (4,851) (13,755)
Change in fair value of derivatives - related parties $ 534 $ (12,934)
v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balances (in shares) at Dec. 31, 2022   82,653,781      
Beginning balances at Dec. 31, 2022 $ (132,711) $ 9 $ 513,614 $ 6 $ (646,340)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 3,363   3,363    
Release of restricted stock units (in shares)   915,206      
Cancellation of shares used to settle payroll tax withholding (in shares)   (246,717)      
Cancellation of shares used to settle payroll tax withholding (345)   (345)    
Issuance of common stock (in shares)   11,900,400      
Issuance of common stock 25,695 $ 1 25,694    
Foreign currency translation adjustment, net of tax 1     1  
Net loss (71,600)       (71,600)
Ending balances (in shares) at Mar. 31, 2023   95,222,670      
Ending balances at Mar. 31, 2023 $ (175,597) $ 10 542,326 7 (717,940)
Beginning balances (in shares) at Dec. 31, 2023 199,133,827 199,133,827      
Beginning balances at Dec. 31, 2023 $ (110,800) $ 21 765,018 7 (875,846)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 2,941   2,941    
Release of restricted stock units (in shares)   657,605      
Cancellation of shares used to settle payroll tax withholding (in shares)   (251,967)      
Cancellation of shares used to settle payroll tax withholding (308)   (308)    
Issuance of common stock (in shares)   7,239,982      
Issuance of common stock 7,207 $ 1 7,206    
Foreign currency translation adjustment, net of tax (5)     (5)  
Net loss $ (46,708)       (46,708)
Ending balances (in shares) at Mar. 31, 2024 206,779,447 206,779,447      
Ending balances at Mar. 31, 2024 $ (147,673) $ 22 $ 774,857 $ 2 $ (922,554)
v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net loss $ (46,708) $ (71,600)
Adjustment to reconcile net loss to net cash used in operating activities    
Stock-based compensation 2,941 3,363
Depreciation and amortization 1,197 2,686
Loss on debt extinguishment 0 1,634
Loss from write-down of property, plant and equipment 65 760
Amortization of right-of-use assets 298 233
Change in fair value of warrants (2,900) 156
Change in fair value of derivatives - related parties (534) 12,934
Changes in operating assets and liabilities:    
Prepaid expenses (196) 406
Inventory 2,677 9,185
Accounts receivable (566) (1,984)
Vendor deposits (204) (917)
Contract assets (4,572) (1,914)
Grant receivable (1,542) (780)
Accounts payable (2,593) (208)
Accrued expenses 6,159 4,991
Interest payable - related party 2,892 2,417
Operating lease liabilities (350) (262)
Contract liabilities 501 (3,450)
Other 527 (381)
Net cash used in operating activities (40,474) (30,478)
Cash flows from investing activities    
Purchases of property, plant and equipment (4,042) (2,897)
Net cash used in investing activities (4,042) (2,897)
Cash flows from financing activities    
Principal payments on finance lease obligations (2) (7)
Proceeds from issuance of convertible notes - related party 0 33,350
Repayment of equipment financing facility (786) (677)
Proceeds from issuance of common stock 7,207 1,250
Repurchase of shares from employees for income tax withholding purposes (308) (345)
Net cash provided by financing activities 6,111 32,455
Effect of exchange rate changes on cash, cash equivalents and restricted cash (6) (1)
Net decrease in cash, cash equivalents and restricted cash (38,411) (921)
Cash, cash equivalents and restricted cash, beginning of the period 84,667 31,223
Cash, cash equivalents and restricted cash, end of the period 46,256 30,302
Non-cash investing and financing activities    
Accrued and unpaid capital expenditures 384 603
Issuance of common stock upon settlement of Yorkville convertible notes 0 24,422
Accrued and unpaid capitalized internal-use software 8 130
Supplemental disclosures    
Cash paid for interest 238 3,690
Nonrelated Party    
Adjustment to reconcile net loss to net cash used in operating activities    
Non-cash interest expense 885 915
Related Party    
Adjustment to reconcile net loss to net cash used in operating activities    
Non-cash interest expense 1,549 11,338
Change in fair value of derivatives - related parties (534) 12,934
Cash flows from financing activities    
Payment of debt issuance costs - related party $ 0 $ (1,116)
v3.24.1.1.u2
Overview
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Overview Overview
Nature of Operations
Eos Energy Enterprises, Inc. (the “Company,” “we,” “us,” “our,” and “Eos”) designs, develops, manufactures and markets innovative energy storage solutions for utility-scale, microgrid and commercial & industrial (“C&I”) applications. Eos developed a broad range of intellectual property with multiple patents covering unique battery chemistry, mechanical product design, energy block configuration and a software operating system (Battery Management System). The Company has only one operating and reportable segment.
Liquidity and Going Concern
As a growth company in the early commercialization stage of its lifecycle, Eos is subject to inherent risks and uncertainties associated with the development of an enterprise. In this regard, substantially all of the Company’s efforts to date have been devoted to the development and manufacturing of battery energy storage systems and complimentary products and services, recruitment of management and technical staff, deployment of capital to expand the Company’s operations to meet customer demand and raising capital to fund the Company’s development. As a result of these efforts, the Company has incurred significant losses and negative cash flows from operations since its inception and expects to continue to incur such losses and negative cash flows for the foreseeable future until such time that the Company can reach a scale of profitability to sustain its operations.
In order to execute its development strategy, the Company has historically relied on outside capital through the issuance of equity, debt and borrowings under financing arrangements (collectively “outside capital”) to fund its cost structure and expects to continue to rely on outside capital for the foreseeable future. While the Company believes it will eventually reach a scale of profitability to sustain its operations, there can be no assurance the Company will be able to achieve such profitability or do so in a manner that does not require its continued reliance on outside capital. Moreover, while the Company has historically been successful in raising outside capital, there can be no assurance the Company will be able to continue to obtain outside capital in the future or do so on terms that are acceptable to the Company.
As of the date the accompanying Unaudited Condensed Consolidated Financial Statements were issued (the “issuance date”), management evaluated the significance of the following negative financial conditions in accordance with Accounting Standard Codification 205-40, Going Concern:
Since its inception, the Company has incurred significant losses and negative cash from operations in order to fund its development. During the three months ended March 31, 2024, the Company incurred a net loss of $46,708, incurred negative cash flows from operations of $40,474 and had an accumulated deficit of $922,554 as of March 31, 2024.
As of March 31, 2024, the Company had $31,773 of unrestricted cash and cash equivalents available to fund the Company’s operations and working capital of $22,097, inclusive of $3,458 of outstanding debt that is currently scheduled to mature within the next twelve months. Additionally, the Company has no additional borrowings available under pre-existing financing arrangements to fund its operations (see Note 12, Borrowings).
The Company has available capacity under its at-the-market (“ATM”) offering program to issue shares of the Company’s common stock, (see also Note 18, Shareholders’ Deficit) to aid in funding the Company’s operations. However, the Company’s ability to secure such funding is dependent upon certain conditions, such as investors’ willingness to purchase the Company’s common stock and at a price that is acceptable to the Company. Accordingly, as of the issuance date, there is no assurance the Company will be able to secure funding under these pre-existing arrangements or on terms that are acceptable to the Company.
Similarly, while the Company has historically been successful in raising additional outside capital to fund the Company’s operations, as of the issuance date no assurance can be provided the Company will be successful in obtaining additional outside capital or on terms that are acceptable to the Company. In this regard, the Company continues to progress through the Department of Energy (“DOE”) Loan Programs Office’s (“LPO”) process for its Title XVII loan. In August 2023, the DOE issued a conditional commitment letter to the Company for a loan of an aggregate principal amount of up to $398,600 through the DOE’s Clean Energy Financing Program. Certain technical, legal and financial conditions must be met and due diligence to the satisfaction of the DOE must be completed before the DOE enters into definitive financing documents with the Company and funds the loan. There can be no assurance that the Company will be able to secure such a loan or on terms that are acceptable to the Company.
The Company is required to remain in compliance with a quarterly minimum financial liquidity covenant under its Senior Secured Term Loan Credit Agreement (“Senior Secured Term Loan”). While the Company was in compliance with this covenant as of March 31, 2024, the Company expects it may be unable to remain in compliance with this covenant beginning on June 30, 2024 and thereafter absent the Company’s ability to secure a waiver or raise additional outside capital. In the event the Company is unable to remain in compliance with the minimum financial liquidity covenant and the other nonfinancial covenants required by the Senior Secured Term Loan and the Company is further unable to cure such noncompliance or secure a waiver, the Lender - Atlas Credit Partners (ACP) Post Oak Credit I LLC (“Atlas”) may, at its discretion, exercise any and all of its existing rights and remedies, which may include, among other things, entering into a forbearance agreement with the Company and/or asserting its rights in the Company’s assets securing the loan. Moreover, the Company’s other lenders may exercise similar rights and remedies under the cross-default provisions of their respective borrowing arrangements with the Company.
Absent an ability to secure additional outside capital in the near term, the Company will be unable to meet its obligations as they become due over the next twelve months beyond the issuance date.
In the event the Company’s ongoing efforts to raise additional outside capital prove unsuccessful, management will be required to seek other strategic alternatives, which may include, among others, a significant curtailment in the Company’s operations, a sale of certain of the Company’s assets, a sale of the entire Company to strategic or financial investors and/or allowing the Company to become insolvent.
These uncertainties raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying Unaudited Condensed Consolidated Financial Statements do not include any adjustments that may result from the outcome of these uncertainties.
v3.24.1.1.u2
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation
The accompanying Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its 100% owned, direct and indirect subsidiaries and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). All intercompany transactions and balances have been eliminated in the preparation of the Unaudited Condensed Consolidated Financial Statements. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The interim financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in our 2023 Annual Report on Form 10-K. These interim results are not necessarily indicative of results for the full year.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassification of Prior Year Presentation
Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.
Recent Accounting Pronouncements
There were no new accounting standards or updates during the three months ended March 31, 2024 that would have a material impact on the Company’s Unaudited Condensed Consolidated Financial Statements.
v3.24.1.1.u2
Revenue Recognition
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
The Company primarily earns revenue from sales of its energy storage systems and services including installation, commissioning and extended warranty services. Product revenues, which are generally recognized at a point in time, and service revenues, which are generally recognized over time, are as follows:
For the Three Months Ended March 31,
20242023
Product revenue$6,501 $8,675 
Service revenue100 160 
Total revenues$6,601 $8,835 
For the three months ended March 31, 2024, the Company had one customer that accounted for 88.1% of total revenue; for the three months ended March 31, 2023, we had one customer that accounted for 97.0% of total revenue.
Lessor revenue
The Company leases battery energy storage systems to one customer through a sales-type lease with a 20-year term. No revenue was recognized from the sales-type lease for the three months ended March 31, 2024 and 2023.
Contract assets and Contract liabilities
The following table provides information about contract assets and contract liabilities from contracts with customers. Contract assets, current, Contract liabilities, current and Contract liabilities, long-term are included separately on the Unaudited Condensed Consolidated Balance Sheets and contract assets expected to be recognized in greater than twelve months are included under Other assets, net.
 
March 31, 2024
December 31, 2023
Contract assets$12,894 $8,322 
Contract liabilities$7,111 $6,610 
The Company recognizes contract assets for certain contracts in which revenue recognition performance obligations have been satisfied but invoicing to the customer has not yet occurred. Contract liabilities primarily relate to consideration received from customers in advance of the Company’s satisfying performance obligations under contractual arrangements. Contract balances are reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.
Contract assets increased by $4,572 during the three months ended March 31, 2024 due to recognition of revenues for which invoicing has not yet occurred. Contract liabilities increased by $501 during the three months ended March 31, 2024, reflecting $798 of revenue recognized from customers and offset by $1,299 in customer advance payments.
Contract liabilities of $2,828 as of March 31, 2024 are expected to be recognized within the next twelve months and long-term contract liabilities of $4,283 are expected to be recognized as revenue in greater than twelve months. Contract assets of $11,075 as of March 31, 2024 are expected to be recognized within the next twelve months and long-term contract assets of $1,819 are expected to be recognized as accounts receivable in greater than twelve months.
Remaining Performance Obligations
Remaining performance obligations (“RPO”) represent the allocated transaction price of unsatisfied or partially unsatisfied performance obligations. The Company expects to recognize revenue related to the RPOs as the performance obligations are satisfied in accordance with the Company’s revenue recognition policy, which can be found in Note 2, Summary of Significant Accounting Policies, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023
v3.24.1.1.u2
Cash, Cash Equivalents and Restricted Cash
3 Months Ended
Mar. 31, 2024
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents and Restricted Cash
Restricted cash - current consists of escrow deposits related to U.S. Custom Bonds insurance and escrow deposits related to our credit card program agreements.
Long-term restricted cash relates to interest that is required to be held in escrow per the Senior Secured Term Loan Agreement in an amount equal to the next four quarterly interest payments owed as of the balance sheet date (see Note 12, Borrowings for further discussion).
The following table reconciles reported amounts from the Unaudited Condensed Consolidated Balance Sheets to Cash, Cash Equivalents and Restricted Cash reported within the Unaudited Condensed Consolidated Statements of Cash Flows:
March 31, 2024
March 31, 2023
Cash and cash equivalents$31,773 $16,127 
Restricted cash - current
2,625 2,725 
Long-term restricted cash11,858 11,450 
    Total cash, cash equivalents and restricted cash $46,256 $30,302 
v3.24.1.1.u2
Inventory
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventory Inventory
The following table provides information about inventory balances:
 
March 31, 2024
December 31, 2023
Raw materials$13,045 $15,487 
Work-in-process490 1,105 
Finished goods858 478 
     Total inventory, net$14,393 $17,070 
v3.24.1.1.u2
Property, Plant and Equipment, Net
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment, Net Property, Plant and Equipment, Net
The following table provides information about property, plant and equipment, net balances:
 Estimated Useful lives
March 31, 2024
December 31, 2023
Equipment
5 to 10 years
$22,484 $20,559 
Finance lease
5 years
504 504 
Furniture
5 to 10 years
2,179 2,103 
Leasehold improvementsLesser of useful life/
remaining lease
7,951 7,718 
Tooling
2 to 3 years
7,866 7,045 
Construction in progress (“CIP”)
20,819 17,958 
     Total61,803 55,887 
Less: Accumulated depreciation (19,061)(18,032)
Total property, plant and equipment, net$42,742 $37,855 
Depreciation expense related to property, plant and equipment was $1,175 and $2,667 for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, the Company recorded a loss from write-down of property, plant and equipment of $65 and $760, respectively, mainly due to replacement of equipment, outsourcing of certain production processes and the shift in production from the Gen 2.3 battery system to the Z3™ battery system.
Included in CIP assets are capitalized interest costs of $850 and $0 for the three months ended March 31, 2024 and 2023, respectively. Depreciation will commence after the assets under construction are placed in service.
v3.24.1.1.u2
Intangible Assets
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Intangible Assets
Intangible assets include patents valued at $400, which represents the cost to acquire the patents. These patents are determined to have useful lives and are amortized into the results of operations over ten years. The Company recorded amortization expense of $10 for the three months ended March 31, 2024 and 2023 related to patents.
The Company capitalized $146 of costs for internal-use software, including $8 of costs capitalized during the three months ended March 31, 2024. The software has a useful life and is amortized into the results of operations over 3 years. The Company recorded amortization expense of $12 and $9 for the three months ended March 31, 2024 and 2023, respectively, related to software.
v3.24.1.1.u2
Notes Receivable, Net and Variable Interest Entities (“VIEs”) Consideration
3 Months Ended
Mar. 31, 2024
Receivables [Abstract]  
Notes Receivable, Net and Variable Interest Entities (“VIEs”) Consideration Notes Receivable, Net and Variable Interest Entities (“VIEs”) Consideration
Notes receivable, net, relates to financing the Company offered to a customer. The Company reports the notes receivable at the principal balance outstanding less an allowance for losses. The estimate of credit losses is based on historical trends, the customer’s financial condition and current economic trends. The Company charges interest at a fixed rate and calculates interest income by applying the effective rate to the outstanding principal balance.
The Company had notes receivable, net, of $827 and $863 outstanding as of March 31, 2024 and December 31, 2023, respectively. These amounts are included in Other assets, net and Other current assets in the accompanying Unaudited Condensed Consolidated Balance Sheets. As of March 31, 2024 and December 31, 2023, the allowance for expected credit loss related to the notes receivable amounted to $36 and $2, respectively.
The customer to whom the Company offers financing through notes receivable is a VIE. However, the Company is not the primary beneficiary, because the Company does not have power to direct the activities of the VIE that most significantly impact the VIE’s economic performance. Therefore, the VIE is not consolidated into the Company’s consolidated financial statements. The maximum loss exposure is limited to the carrying value of notes receivable as of the balances sheet dates.
v3.24.1.1.u2
Accrued Expenses
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses Accrued Expenses
Accrued expenses were as follows:
March 31, 2024
December 31, 2023
Accrued payroll$7,273 $4,553 
Warranty reserve (1)
5,513 6,197 
Accrued legal and professional expenses11,058 10,710 
Provision for contract losses3,205 3,351 
Insurance premium payable, current2,730 2,605 
Interest payable, current
3,684 — 
Other5,151 4,916 
Total accrued expenses$38,614 $32,332 
(1) Refer to the table below for the warranty reserve activity for the three months ended March 31, 2024 and 2023.
The following table summarizes warranty reserve activity:

Three Months Ended March 31,
20242023
Warranty reserve - beginning of period$6,197 $3,836 
Additions for current period deliveries265 357 
Changes in the warranty reserve estimate(949)— 
Warranty costs incurred— (221)
Warranty reserve - end of period$5,513 $3,972 
v3.24.1.1.u2
Government Grants
3 Months Ended
Mar. 31, 2024
Government Assistance [Abstract]  
Government Grants Government Grants
Inflation Reduction Act of 2022 (“IRA”)
On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 into law. The IRA has significant economic incentives for both energy storage customers and manufacturers for projects placed in service after December 31, 2022. Starting in 2023, there are Production Tax Credits under Internal Revenue Code 45X (“PTC”), that can be claimed on battery components manufactured in the U.S. and sold to U.S. or foreign customers. The tax credits available to manufacturers include a credit for ten percent of the cost incurred to make electrode active materials in addition to credits of $35 per kWh of capacity of battery cells and $10 per kWh of capacity of battery modules. These credits are cumulative, meaning that companies will be able to claim each of the available tax credits based on the battery components produced and sold through 2029, after which the PTC will begin to gradually phase down through 2032. In June 2023, the IRS issued temporary and proposed regulations related to applicable tax credit transferability and direct pay provisions of the Inflation Reduction Act. The Company has reviewed these regulations and believes they do not have a material impact on the financial statements.
Since the PTC is a refundable credit (i.e., a credit with a direct-pay option available), the PTC is outside the scope of ASC 740. Therefore, the Company accounts for the PTC under a government grant model. GAAP does not address the accounting for government grants received by a business entity that are outside the scope of ASC 740. The Company’s accounting policy is to analogize to IAS 20, Accounting for Government Grants and Disclosure of Government Assistance, under IFRS Accounting Standards. Under IAS 20, once it is reasonably assured that the entity will comply with the conditions of the grant, the grant money is recognized on a systematic basis over the periods in which the entity recognizes the related expenses or losses for which the grant money is intended to compensate. The Company recognizes grants once it is probable that both of the following conditions will be met: (1) the Company is eligible to receive the grant and (2) the Company is able to comply with the relevant conditions of the grant.
The PTC is recorded as the applicable items are produced and sold and the conditions in the preceding paragraph are met. For the three months ended March 31, 2024 and 2023, the Company recognized PTC of $1,542 and $798, respectively, as a reduction of cost of goods sold on the Unaudited Condensed Consolidated Statement of Operations and Comprehensive Loss. As of March 31, 2024 and December 31, 2023, grant receivable related to the PTC in the amount of $4,798 and $3,256, respectively, is recorded in the Unaudited Condensed Consolidated Balance Sheets
v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
2021 Convertible Note Payable
In July 2021, the Company issued a convertible note in the aggregate principal amount of $100,000 to Spring Creek Capital, LLC, a wholly-owned, indirect subsidiary of Koch Industries, Inc. (the “2021 Convertible Note”). In connection with the 2021 Convertible Note, the Company paid $3,000 to B. Riley Securities, Inc., a related party, who acted as a placement agent. Refer to Note 12, Borrowings, for additional information.
AFG Convertible Notes
In January 2023, the Company issued and sold $13,750 of 26.5% Convertible Senior PIK Notes due in 2026 (“AFG Convertible Notes”) to Great American Insurance Company, Ardsley Partners Renewable Energy, LP, CCI SPV III, LP, Denman Street LLC, John B. Bending Irrevocable Children’s Trust, John B. Berding and AE Convert, LLC, a Delaware limited liability company managed by Russell Stidolph, a director of the Company (together, the “Purchasers”). In connection with the issuance and sale of the AFG Convertible Notes, the Company entered into an investment agreement (the “Investment Agreement”) with the Purchasers. Refer to Note 12, Borrowings, for additional information.
Standby Equity Purchase Agreement
On April 28, 2022, the Company entered into the Standby Equity Purchase Agreement (“SEPA”). Pursuant to the SEPA, the Company had the right, but not the obligation, to sell to Yorkville shares of its common stock at the Company’s request. On August 23, 2023, the Company and Yorkville terminated the SEPA, as amended, by mutual written consent. See Note 12, Borrowings for pre-advance loans in form of convertible promissory notes and Note 18, Shareholders' Deficit for additional information.
Warrants
The Company issued private placement warrants to B. Riley Financial, Inc. in conjunction with its initial public offering 2020 (“IPO warrants”). As of March 31, 2024 and December 31, 2023, 274,400 IPO warrants were outstanding for both periods, with a fair value of $49 and $55, respectively.
v3.24.1.1.u2
Borrowings
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Borrowings Borrowings
The Company’s debt obligations at carrying value consist of the following related and third-party borrowings:
March 31, 2024
December 31, 2023
Maturity DateBorrowing OutstandingCarrying Value*Borrowing OutstandingCarrying Value*
2021 Convertible Note Payable
June 2026
$115,815 $96,033 $115,815 $94,386 
Senior Secured Term Loan
March 2026
100,000 86,756 100,000 85,624 
AFG Convertible Notes
June 2026
17,429 17,917 17,429 18,139 
Equipment financing facility
April 2026
4,931 4,924 5,718 5,710 
    Total borrowings
238,175 205,630 238,962 203,859 
Current portion
3,458 3,458 3,332 3,332 
Total borrowings, non-current
$234,717 $202,172 $235,630 $200,527 
*Carrying value includes unamortized deferred financing costs, unamortized discounts and fair value of embedded derivative liabilities.
2021 Convertible Note Payable – Related Party
On July 6, 2021, the Company entered into an investment agreement with Spring Creek Capital, LLC, a wholly-owned, indirect subsidiary of Koch Industries, Inc. The investment agreement provides for the issuance and sale to Koch Industries of the 2021 Convertible Note in the aggregate principal amount of $100,000.
The 2021 Convertible Note contains an embedded derivative feature, which is presented on the Unaudited Condensed Consolidated Balance Sheets as a component of Convertible notes payable - related party. See Note 14, Fair Value Measurement for the assumptions used to determine the fair value of the embedded derivative as of March 31, 2024 and December 31, 2023.
Interest expense recognized on the 2021 Convertible Note is as follows:
Three Months Ended March 31,
2024
2023
Contractual interest expense$1,737 $1,637 
Amortization of debt discount1,531 1,207 
Amortization of debt issuance costs148 117 
    Total$3,416 $2,961 

The balances for the 2021 Convertible Note are as follows:
March 31, 2024
December 31, 2023
Principal$115,815 $115,815 
Unamortized debt discount(18,081)(19,612)
Unamortized debt issuance costs(1,747)(1,895)
Embedded conversion feature46 78 
     Aggregate carrying value$96,033 $94,386 
The Company is obligated to repay all contractual interest attributable to the 2021 Convertible Note in-kind on a semi-annual basis, in accordance with the terms under the Senior Secured Term Loan. Therefore, as of March 31, 2024 and December 31, 2023, interest payable attributable to the 2021 Convertible Note was $1,737 and $0, respectively.
AFG Convertible Notes - Related Party
On January 18, 2023, the Company entered into the Investment Agreement with the Purchasers relating to the issuance and sale to the Purchasers of $13,750 in aggregate principal amount of the Company’s AFG Convertible Notes. The AFG Convertible Notes bear interest at a rate of 26.5% per annum, which is entirely paid-in-kind (“PIK Interest”) semi-annually in arrears on June 30 and December 30. It is expected that the Notes will mature on June 30, 2026, subject to earlier conversion, redemption or repurchase. The AFG Convertible Notes are convertible into shares of the Company’s common stock, par value $0.0001 per share, based on an initial conversion price of approximately $1.67 per share subject to customary anti-dilution and other adjustments. The Company has the right to settle conversions in shares of common stock, cash, or any combination thereof.
The Conversion Option includes an exercise contingency, which requires the Company to obtain shareholder approval for conversions subject to the Exchange Cap. If shareholder approval is not obtained, following commercially reasonable efforts, the Company will be required to settle the conversion in excess of the Exchange Cap in cash. Since settlement in cash may be required in absence of shareholder approval, the embedded conversion feature fails the equity classification guidance in ASC 815 and is thus precluded from being classified in equity. Therefore, the embedded conversion feature is required to be bifurcated from the AFG Convertible Notes and accounted for at fair value at each reporting date, with changes in fair value recognized on the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss. The embedded derivative is presented on the Unaudited Condensed Consolidated Balance Sheets as a component of Convertible notes payable - related party. The fair value of the embedded derivative was $3,843 and $4,345 as of March 31, 2024 and December 31, 2023, respectively.
The fair value of the AFG Convertible Notes at issuance was $16,623, which was greater than the proceeds received. The Company recorded the difference of $2,873 as interest expense for the three months ended March 31, 2023 on the Unaudited Condensed Consolidated Statement of Operations and Comprehensive Loss.
Interest expense recognized on the AFG Convertible Notes is as follows:
Three Months Ended March 31,
2024
2023
Contractual interest expense$1,155 $779 
Amortization of debt discount218 148 
Amortization of debt issuance costs62 42 
    Total$1,435 $969 
The balances for the AFG Convertible Notes are as follows:
March 31, 2024
December 31, 2023
Principal$17,429 $17,429 
Unamortized debt discount(2,617)(2,835)
Unamortized debt issuance costs(738)(800)
Embedded conversion feature3,843 4,345 
     Aggregate carrying value$17,917 $18,139 
The Company is obligated to repay all contractual interest attributable to the AFG Convertible Notes in-kind on a semi-annual basis, in accordance with the terms of the Investment Agreement. Therefore, as of March 31, 2024 and December 31, 2023, interest payable attributable to the AFG Convertible Notes was $1,155 and $0, respectively.
Senior Secured Term Loan
On July 29, 2022, the Company entered into a $100,000 Senior Secured Term Loan Credit Agreement with Atlas Credit Partners (ACP) Post Oak Credit I LLC, as administrative agent for the lenders and collateral agent for the secured parties. The Senior Secured Term Loan is scheduled to mature on the earlier of (i) July 29, 2026 and (ii) 91 days prior to the current maturity date of the 2021 Convertible Note of June 30, 2026. The Company has the right at any time to prepay any Borrowing in whole or in part in an amount of not less than $500.
The outstanding principal balance of the Senior Secured Term Loan bears interest, at the applicable margin plus, at the Company’s election, either (i) the benchmark secured overnight financing rate (“SOFR”), which is a per annum rate equal to (y) the Adjusted Term SOFR plus 0.2616%, or (ii) the alternate base rate (“ABR”), which is a per annum rate equal to the greatest of (x) the Prime Lending Rate, (y) the NYFRB Rate (as defined in the agreement) plus 0.5% and (z) the SOFR. The applicable margin under the Credit Agreement is 8.5% per annum with respect to SOFR loans and 7.5% per annum with respect to ABR loans. Interest on the Senior Secured Term Loan accrues at a variable interest rate and interest payments are due quarterly. The Company may elect to convert SOFR Loans to ABR and ABR Loans to SOFR. As of March 31, 2024, the interest rate in effect for the Senior Secured Term Loan interest payment was 14.11%.
Any repayment of principal prior to the second anniversary of the issuance date is subject to a call premium. The call premium is equal to the present value of all interest payments due through June 30, 2024, calculated using a discount rate equal to the applicable treasury rate as of the repayment date plus 50 basis points. The Company deemed that the fair value of the embedded derivative features which qualify for bifurcation was de minimis.
Additionally, interest is required to be escrowed based on the principle outstanding. This amount was $11,858 at March 31, 2024 and $11,755 at December 31, 2023. This escrowed and restricted cash is presented on a separate line item on the Unaudited Condensed Consolidated Balance Sheets as Long-term restricted cash.
The agreements also contain customary affirmative and negative covenants. They limit the Company’s and its subsidiaries’ ability to incur indebtedness, make restricted payments, including cash dividends on its common stock, make certain investments, loans and advances, enter into mergers and acquisitions, sell, assign, transfer or otherwise dispose of its assets, enter into transactions with its affiliates and engage in sale and leaseback transactions, among other restrictions. Furthermore, the limitation on the Company’s ability to incur indebtedness also requires payment of principal and interest in kind on the 2021 Convertible Note. While the Company was in compliance with this covenant as of March 31, 2024 , absent the Company’s ability to secure a waiver or raise additional outside capital, the Company expects it may be unable to remain in compliance with this covenant beginning on June 30, 2024 and thereafter (see Note 1, Overview for further discussion).
The following table summarizes interest expense recognized:
Three Months Ended March 31,
2024
2023
Contractual interest expense$3,684 $3,373 
Amortization of debt discount115 93 
Amortization of debt issuance costs1,017 822 
Total $4,816 $4,288 
The Senior Secured Term Loan balance is as follows:
March 31, 2024
December 31, 2023
Principal$100,000 $100,000 
Unamortized debt discount(1,344)(1,459)
Unamortized debt issuance costs(11,900)(12,917)
     Aggregate carrying value$86,756 $85,624 
Equipment Financing facility
The Company entered into an agreement on September 30, 2021 with Trinity Capital Inc. (“Trinity”) for a $25,000 equipment financing facility, the proceeds of which will be used to acquire certain manufacturing equipment, subject to Trinity’s approval. Each draw is executed under a separate payment schedule (a “Schedule”) that constitutes a separate financial instrument. The financing fees included in each Schedule are established through monthly payment factors determined by Trinity. Such monthly payment factors are based on the Prime Rate reported in The Wall Street Journal in effect on the first day of the month in which a Schedule is executed. The Company has drawn a portion of the facility as follows:
Date of Draw
Gross Amount of Initial Draw
Coupon Interest RateDebt Issuance Costs
September 2021$7,000 14.3%$175 
September 20224,216 16.2%96 
    Total Equipment Financing loans$11,216 $271 
As of March 31, 2024 and December 31, 2023, total equipment financing carrying value was $4,924 and $5,710, respectively of which $3,458 and $3,332 are recorded as a current liability on the Unaudited Condensed Consolidated Balance Sheets, respectively. The Company recognized $208 and $317 for the three months ended March 31, 2024 and 2023 as interest expense attributable to the equipment financing agreement, respectively.
Yorkville Convertible Promissory Notes - Related Party
In December 2022, February 2023, and March of 2023, the Company issued additional convertible promissory notes with an aggregate principal amount of $22,000 in a private placement to Yorkville under the second and third supplemental agreements to the SEPA, respectively. The fair values of the January 2023 and February 2023 Promissory Notes at issuance were greater than the proceeds received. Accordingly, the Company recorded the excess of fair value of these Promissory Notes over the proceeds received as Interest expense - related party in the amount of $6,952, for the three months ended March 31, 2023, which is reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
During the first quarter of 2023, Yorkville delivered Investor Notices requiring the Company to issue and sell an aggregate of 11,216,492 shares of common stock to Yorkville to offset all outstanding amounts owed to Yorkville under the outstanding Promissory Notes. The Company recognized a loss on debt extinguishment from the issuance of common stock from the December 2022, January 2023, and February 2023 Promissory Notes of $1,634 for the three months ended March 31, 2023, which is reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
The conversion feature for each of the Promissory Notes discussed above did not qualify for the scope exception to derivative accounting, therefore bifurcation was required for each issuance. Upon extinguishment of each Promissory Note, the embedded derivatives were adjusted to their fair value. This remeasurement resulted in net gains of $55 for the three months ended March 31, 2023, which is included in change in fair value of derivatives - related parties on the Condensed Consolidated Statements of Operations and Comprehensive Loss.
As of December 31, 2023, there were no outstanding amounts under the Yorkville Promissory Notes.
v3.24.1.1.u2
Warrants Liability
3 Months Ended
Mar. 31, 2024
Other Liabilities Disclosure [Abstract]  
Warrants Liability Warrants Liability
In April 2023, the Company issued 16,000,000 shares of common stock and 16,000,000 private placement warrants to purchase shares of common stock. In May 2023, the Company issued another 3,601,980 shares of common stock and 3,601,980 private placement warrants to purchase shares of common stock (the “April 2023 warrants” and “May 2023 warrants”, respectively).
In December 2023, the Company issued in a combined public offering 34,482,759 shares of common stock and 34,482,759 accompanying common warrants to purchase shares of common stock (the "December 2023 warrants").
The amount of warrants outstanding and fair value for all warrants as of March 31, 2024 and December 31, 2023 are as follows:
March 31, 2024
December 31, 2023
Warrants
Outstanding
Fair ValueWarrants
Outstanding
Fair Value
IPO warrants274,400 $49 274,400 $55 
April 2023 warrants16,000,000 5,494 16,000,000 6,276 
May 2023 warrants3,601,980 1,357 3,601,980 1,544 
December 2023 warrants34,482,759 17,661 34,482,759 19,586 
Total54,359,139$24,561 54,359,139$27,461 
All warrants are measured at fair value at each reporting period. For all warrants in aggregate, the change in fair value for the three months ended March 31, 2024 and 2023 has been recognized in change in fair value of warrants on the Company’s Condensed Consolidated Statements of Operations and Comprehensive Loss. The fair value for the warrants is included in Warrants liability on the Condensed Consolidated Balance Sheets. See Note 14, Fair Value Measurements for further information.
v3.24.1.1.u2
Fair Value Measurement
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurement Fair Value Measurement
The Company’s financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, notes receivable, contract assets, accounts payable, warrants, convertible notes payable — related party, contract liabilities and long-term debt.
Accounting standards establish a hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels. The fair value hierarchy gives the highest priority to quoted market prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Accounting standards require financial assets and liabilities to be classified based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and the exercise of this judgment may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.
The carrying value of cash and cash equivalents, restricted cash, accounts receivable, contract assets, contract liabilities and accounts payable are considered to be representative of their fair value due to the short maturity of these instruments.
The table below summarizes the fair values of certain liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and their designations among the three fair value measurement categories:
March 31, 2024
December 31, 2023
Level 1Level 2Level 3Level 1Level 2Level 3
Liabilities
  Warrants
$— $49 $24,512 $— $55 $27,406 
  Embedded derivatives
$— $— $3,889 $— $— $4,423 
Warrants Liabilities
The IPO warrants are classified as Level 2 financial instruments in the table above. They are valued on the basis of the quoted price of the Company’s public warrants, adjusted for insignificant difference between the public warrants and the private placement warrants.
The April 2023 warrants, May 2023 warrants and December 2023 warrants are classified as Level 3 financial instruments in the table above. The Company estimated the fair value of these warrants using the Black-Scholes model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, risk-free interest rate, volatility and time to expiration. The volatility involves unobservable inputs classified as Level 3 of the fair value hierarchy.
The inputs used to determine the fair value of the April 2023 warrants, May 2023 warrants and the December 2023 warrants are as follows:
April 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.54 years4.79 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
May 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.29 years4.54 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
December 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.71 years4.96 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
Embedded derivatives
The Company estimated the fair value of the embedded conversion features in the 2021 Convertible Note and the AFG Convertible Notes using a binomial lattice model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, dividend yield, risk-free interest rate, the effective debt yield and expected volatility. The effective debt yield and volatility involve unobservable inputs classified as Level 3 of the fair value hierarchy.
The inputs used to determine the fair value of the embedded derivative liabilities are as follows:
2021 Convertible Note Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield— %— %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
AFG Convertible Notes Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield— %— %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
Level 3 Liabilities

Level 3 liabilities are measured at fair value on a recurring basis using significant unobservable inputs. The following table summarizes the changes in the fair value of liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and are designated as Level 3:
Three Months Ended March 31,

2024
2023
Embedded derivatives
Balance at beginning of the period$4,423 $1,945 
Additions— 14,799 
Change in fair value of derivatives - related parties1
(534)4,511 
Balance at end of the period$3,889 $21,255 
Warrants
Balance at beginning of the period$27,406 $— 
Additions— — 
Change in fair value of warrants
(2,894)— 
Balance at end of the period$24,512 $— 
1 Includes loss on debt extinguishment from Yorkville Promissory Note Conversions for the three months ended March 31, 2023.

The estimated fair value of financial instruments not carried at fair value in the Unaudited Condensed Consolidated Balance Sheets was as follows:
Level in Fair Value Hierarchy
March 31, 2024
December 31, 2023
Carrying ValueFair ValueCarrying ValueFair Value
Notes receivable3$827 $721 $863 $719 
2021 Convertible Note*
396,033 63,034 94,386 57,998 
Senior Secured Term Loan 386,756 64,117 85,624 61,360 
AFG Convertible Notes*317,917 19,076 18,139 18,352 
Equipment financing facility34,924 4,261 5,710 4,826 
  Total$206,457 $151,209 $204,722 $143,255 
*Includes the embedded derivative liabilities.
v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Lease Commitments
The Company has lease commitments under lease agreements. As of March 31, 2024, future lease payments amounted to $5,568.
Minimum Volume Commitment
In June 2022, the Company entered into a long-term supply agreement with a minimum volume commitment with a third party that provides services to process certain raw materials. Any purchase order issued under this supply agreement will be non-cancellable. If the Company fails to order the guaranteed minimum volume defined in the contract at the end of the term, the Company will be required to pay the counterparty an amount equal to the shortfall, if any, multiplied by a fee. The Company believes it will meet the minimum volume commitment and no shortfall penalty has been accrued as of March 31, 2024.
Legal Proceedings
Class Action Complaints
v3.24.1.1.u2
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Stock-based compensation expense included in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows:
Three Months Ended March 31,
2024
2023
Stock options$174 $740 
Restricted stock units2,767 2,623 
Total$2,941 $3,363 
The stock compensation expense has been recorded in cost of goods sold, research and development expenses and selling, general and administrative expenses.
As of March 31, 2024, total unrecognized compensation expense was $12,448 of which $12,358 was attributable to unvested restricted stock units (“RSU”) and $90 was attributable to unvested stock options. Compensation expense for these unvested awards is expected to be recognized over a weighted-average remaining vesting period of 2.1 years for RSUs and 0.1 years for stock options
v3.24.1.1.u2
Income Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
For the three months ended March 31, 2024 and 2023, income tax expense was $25 and $10, respectively, related to state margin taxes and taxable earnings from foreign operations. The income tax expense differs from the amount computed by applying the statutory U.S. federal income tax rate of 21% to the loss before income taxes. This is due to non-taxable income, foreign operations and pre-tax losses for which no tax benefit can be recognized for U.S. income tax purposes.
The Company estimates and applies the annual effective tax rate to its ordinary earnings each interim period. Any significant unusual or infrequent items are not included in the estimation of the annual effective tax rate; instead, these items and their related income tax expense are separately stated in the interim period in which they occur. The quarterly estimate of the annual effective tax rate and related tax expense is subject to variation due to a multitude of factors, including, but are not limited to, the inability to accurately predict the Company’s pre-tax and taxable income and loss.
At each balance sheet date, management assesses the likelihood that the Company will be able to realize its deferred tax assets. Management considered all available positive and negative evidence in assessing the need for a valuation allowance. The realization of deferred tax assets depends on the generation of sufficient taxable income of the appropriate character and in the appropriate taxing jurisdiction during the future periods in which the related temporary differences become deductible. Management has determined that it is unlikely that the Company will be able to utilize its U.S. deferred tax assets at March 31, 2024 and December 31, 2023 due to cumulative losses. Therefore, the Company has a valuation allowance against its net U.S. deferred tax assets.
As of March 31, 2024 and December 31, 2023, the Company has unrecognized tax benefits associated with uncertain tax positions that, if recognized, would not affect the effective tax rate on income from continuing operations. The Company is not currently under examination by any taxing jurisdiction and none of the uncertain tax positions are expected to reverse within the next 12 months.
The Company files income tax returns in U.S. federal and various state jurisdictions, as well as in Italy and India. The open tax years for federal returns are 2020 and forward and open tax years for state returns are generally 2019 and forward. In addition, net operating losses generated in closed years and utilized in open years are subject to adjustment by the tax authorities.
v3.24.1.1.u2
Shareholders’ Deficit
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Shareholders’ Deficit Shareholders’ Deficit
Preferred Stock
The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors. At March 31, 2024 and December 31, 2023, there were no shares of preferred stock issued or outstanding.
Common Stock
The Company is authorized to issue 300,000,000 shares of common stock at $0.0001 par value as of March 31, 2024. The holders of the Company’s common stock are entitled to one vote for each share held. At March 31, 2024 and December 31, 2023, there were 206,779,447 and 199,133,827 shares of common stock issued and outstanding.
Treasury Stock
The Company recorded treasury stock of $308 and $345 for the three months ended March 31, 2024 and 2023 for shares withheld from employees to cover the payroll tax liability of RSUs vested, respectively. The treasury stock was immediately retired.
Warrants Liability
The Company has outstanding private warrants from the IPO warrants, the April 2023 warrants, the May 2023 warrants and the December 2023 warrants. Warrants liability is included separately on the Unaudited Condensed Consolidated Balance Sheets. See Note 13, Warrants Liability for further discussion.
Public Warrants
The Company sold warrants to purchase 9,075,000 shares of the Company’s common stock in a public offering on May 22, 2020 (the “Public Warrants”). Each Public Warrant entitles the holder to purchase a share of common stock at a price of $11.50 per share. There were no Public Warrants exercised during the three months ended March 31, 2024 and 2023. As of March 31, 2024 and December 31, 2023, there were 7,052,254 public warrants outstanding for both periods.
Standby Equity Purchase Agreement
During the three months ended March 31, 2023, total funds raised under the SEPA, inclusive of proceeds received from the Yorkville Convertible Promissory Notes, were $20,850. During the three months ended March 31, 2023, total shares issued under the SEPA were 11,900,400.
On August 23, 2023, the Company and Yorkville terminated the SEPA, as amended, by mutual written consent. At the time of termination, there were no outstanding borrowings, advance notices or shares of Common Stock to be issued under the SEPA. In addition, there were no fees due by the Company or Yorkville in connection with the termination of the SEPA.
At-the-Market Offering Program
The Company has a sales agreement with Cowen and Company, LLC (“Cowen”), with respect to an at-the-market offering (“ATM”) program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, having an aggregate offering price of up to $200,000 through Cowen as its sales agent and/or principal.
During the three months ended March 31, 2024, the Company sold 7,239,982 shares raising proceeds of $7,206, net of fees paid to Cowen, at an average selling price of $1.03 per share. There were no shares issued under the ATM offering program for the three months ended March 31, 2023.
Earnings Per Share
Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the weighted average number of shares of common stock outstanding during the period. Other potentially dilutive common shares and the related impact to earnings are considered when calculating EPS on a diluted basis. Since the Company incurred a net loss for the three months ended March 31, 2024 and 2023, the potential dilutive shares from stock options, restricted stock units, warrants and Convertible Notes were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented. Therefore, basic and diluted EPS are computed using the same number of weighted-average shares for the three months ended March 31, 2024 and 2023.
The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:

Three Months Ended March 31,
2024
2023
Stock options and restricted stock units9,048,602 6,987,945 
Warrants
61,411,393 7,326,654 
Convertible Notes
16,226,124 16,950,606 
v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
On April 22, 2024, the Company closed an agreement with Banyan Software, Inc. to accelerate its 2023 Production Tax Credit monetization. The Company received $2,303 in cash. This amount relates to a portion of the PTC grant receivable as of March 31, 2024, as discussed in Note 10, Government Grants.
v3.24.1.1.u2
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its 100% owned, direct and indirect subsidiaries and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). All intercompany transactions and balances have been eliminated in the preparation of the Unaudited Condensed Consolidated Financial Statements. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The interim financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in our 2023 Annual Report on Form 10-K. These interim results are not necessarily indicative of results for the full year.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Reclassification of Prior Year Presentation
Reclassification of Prior Year Presentation
Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
There were no new accounting standards or updates during the three months ended March 31, 2024 that would have a material impact on the Company’s Unaudited Condensed Consolidated Financial Statements.
v3.24.1.1.u2
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue Recognition Product revenues, which are generally recognized at a point in time, and service revenues, which are generally recognized over time, are as follows:
For the Three Months Ended March 31,
20242023
Product revenue$6,501 $8,675 
Service revenue100 160 
Total revenues$6,601 $8,835 
Schedule of Information about Contract Assets and Liabilities from Contracts with Customers
The following table provides information about contract assets and contract liabilities from contracts with customers. Contract assets, current, Contract liabilities, current and Contract liabilities, long-term are included separately on the Unaudited Condensed Consolidated Balance Sheets and contract assets expected to be recognized in greater than twelve months are included under Other assets, net.
 
March 31, 2024
December 31, 2023
Contract assets$12,894 $8,322 
Contract liabilities$7,111 $6,610 
v3.24.1.1.u2
Cash, Cash Equivalents and Restricted Cash (Tables)
3 Months Ended
Mar. 31, 2024
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents, and Restricted Cash
The following table reconciles reported amounts from the Unaudited Condensed Consolidated Balance Sheets to Cash, Cash Equivalents and Restricted Cash reported within the Unaudited Condensed Consolidated Statements of Cash Flows:
March 31, 2024
March 31, 2023
Cash and cash equivalents$31,773 $16,127 
Restricted cash - current
2,625 2,725 
Long-term restricted cash11,858 11,450 
    Total cash, cash equivalents and restricted cash $46,256 $30,302 
Schedule of Cash, Cash Equivalents, and Restricted Cash
The following table reconciles reported amounts from the Unaudited Condensed Consolidated Balance Sheets to Cash, Cash Equivalents and Restricted Cash reported within the Unaudited Condensed Consolidated Statements of Cash Flows:
March 31, 2024
March 31, 2023
Cash and cash equivalents$31,773 $16,127 
Restricted cash - current
2,625 2,725 
Long-term restricted cash11,858 11,450 
    Total cash, cash equivalents and restricted cash $46,256 $30,302 
v3.24.1.1.u2
Inventory (Tables)
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Components of Inventories
The following table provides information about inventory balances:
 
March 31, 2024
December 31, 2023
Raw materials$13,045 $15,487 
Work-in-process490 1,105 
Finished goods858 478 
     Total inventory, net$14,393 $17,070 
v3.24.1.1.u2
Property, Plant and Equipment, Net (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Components of Property, Plant and Equipment, Net
The following table provides information about property, plant and equipment, net balances:
 Estimated Useful lives
March 31, 2024
December 31, 2023
Equipment
5 to 10 years
$22,484 $20,559 
Finance lease
5 years
504 504 
Furniture
5 to 10 years
2,179 2,103 
Leasehold improvementsLesser of useful life/
remaining lease
7,951 7,718 
Tooling
2 to 3 years
7,866 7,045 
Construction in progress (“CIP”)
20,819 17,958 
     Total61,803 55,887 
Less: Accumulated depreciation (19,061)(18,032)
Total property, plant and equipment, net$42,742 $37,855 
v3.24.1.1.u2
Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses
Accrued expenses were as follows:
March 31, 2024
December 31, 2023
Accrued payroll$7,273 $4,553 
Warranty reserve (1)
5,513 6,197 
Accrued legal and professional expenses11,058 10,710 
Provision for contract losses3,205 3,351 
Insurance premium payable, current2,730 2,605 
Interest payable, current
3,684 — 
Other5,151 4,916 
Total accrued expenses$38,614 $32,332 
(1) Refer to the table below for the warranty reserve activity for the three months ended March 31, 2024 and 2023.
Schedule of Warranty Reserve Activity
The following table summarizes warranty reserve activity:

Three Months Ended March 31,
20242023
Warranty reserve - beginning of period$6,197 $3,836 
Additions for current period deliveries265 357 
Changes in the warranty reserve estimate(949)— 
Warranty costs incurred— (221)
Warranty reserve - end of period$5,513 $3,972 
v3.24.1.1.u2
Borrowings (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
The Company’s debt obligations at carrying value consist of the following related and third-party borrowings:
March 31, 2024
December 31, 2023
Maturity DateBorrowing OutstandingCarrying Value*Borrowing OutstandingCarrying Value*
2021 Convertible Note Payable
June 2026
$115,815 $96,033 $115,815 $94,386 
Senior Secured Term Loan
March 2026
100,000 86,756 100,000 85,624 
AFG Convertible Notes
June 2026
17,429 17,917 17,429 18,139 
Equipment financing facility
April 2026
4,931 4,924 5,718 5,710 
    Total borrowings
238,175 205,630 238,962 203,859 
Current portion
3,458 3,458 3,332 3,332 
Total borrowings, non-current
$234,717 $202,172 $235,630 $200,527 
*Carrying value includes unamortized deferred financing costs, unamortized discounts and fair value of embedded derivative liabilities.
The Senior Secured Term Loan balance is as follows:
March 31, 2024
December 31, 2023
Principal$100,000 $100,000 
Unamortized debt discount(1,344)(1,459)
Unamortized debt issuance costs(11,900)(12,917)
     Aggregate carrying value$86,756 $85,624 
Date of Draw
Gross Amount of Initial Draw
Coupon Interest RateDebt Issuance Costs
September 2021$7,000 14.3%$175 
September 20224,216 16.2%96 
    Total Equipment Financing loans$11,216 $271 
Schedule of Interest Expense
Interest expense recognized on the 2021 Convertible Note is as follows:
Three Months Ended March 31,
2024
2023
Contractual interest expense$1,737 $1,637 
Amortization of debt discount1,531 1,207 
Amortization of debt issuance costs148 117 
    Total$3,416 $2,961 
Interest expense recognized on the AFG Convertible Notes is as follows:
Three Months Ended March 31,
2024
2023
Contractual interest expense$1,155 $779 
Amortization of debt discount218 148 
Amortization of debt issuance costs62 42 
    Total$1,435 $969 
The following table summarizes interest expense recognized:
Three Months Ended March 31,
2024
2023
Contractual interest expense$3,684 $3,373 
Amortization of debt discount115 93 
Amortization of debt issuance costs1,017 822 
Total $4,816 $4,288 
Schedule of Balances Recognized upon Issuance of Convertible Notes
The balances for the 2021 Convertible Note are as follows:
March 31, 2024
December 31, 2023
Principal$115,815 $115,815 
Unamortized debt discount(18,081)(19,612)
Unamortized debt issuance costs(1,747)(1,895)
Embedded conversion feature46 78 
     Aggregate carrying value$96,033 $94,386 
The balances for the AFG Convertible Notes are as follows:
March 31, 2024
December 31, 2023
Principal$17,429 $17,429 
Unamortized debt discount(2,617)(2,835)
Unamortized debt issuance costs(738)(800)
Embedded conversion feature3,843 4,345 
     Aggregate carrying value$17,917 $18,139 
v3.24.1.1.u2
Warrants Liability (Tables)
3 Months Ended
Mar. 31, 2024
Other Liabilities Disclosure [Abstract]  
Schedule of Common Stock Warrants Outstanding and Fair Value
The amount of warrants outstanding and fair value for all warrants as of March 31, 2024 and December 31, 2023 are as follows:
March 31, 2024
December 31, 2023
Warrants
Outstanding
Fair ValueWarrants
Outstanding
Fair Value
IPO warrants274,400 $49 274,400 $55 
April 2023 warrants16,000,000 5,494 16,000,000 6,276 
May 2023 warrants3,601,980 1,357 3,601,980 1,544 
December 2023 warrants34,482,759 17,661 34,482,759 19,586 
Total54,359,139$24,561 54,359,139$27,461 
v3.24.1.1.u2
Fair Value Measurement (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Liabilities
The table below summarizes the fair values of certain liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and their designations among the three fair value measurement categories:
March 31, 2024
December 31, 2023
Level 1Level 2Level 3Level 1Level 2Level 3
Liabilities
  Warrants
$— $49 $24,512 $— $55 $27,406 
  Embedded derivatives
$— $— $3,889 $— $— $4,423 
Schedule of Assumptions used to Determine Fair Value of Warrants and Embedded Derivative Liabilities
The IPO warrants are classified as Level 2 financial instruments in the table above. They are valued on the basis of the quoted price of the Company’s public warrants, adjusted for insignificant difference between the public warrants and the private placement warrants.
The April 2023 warrants, May 2023 warrants and December 2023 warrants are classified as Level 3 financial instruments in the table above. The Company estimated the fair value of these warrants using the Black-Scholes model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, risk-free interest rate, volatility and time to expiration. The volatility involves unobservable inputs classified as Level 3 of the fair value hierarchy.
The inputs used to determine the fair value of the April 2023 warrants, May 2023 warrants and the December 2023 warrants are as follows:
April 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.54 years4.79 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
May 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.29 years4.54 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
December 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.71 years4.96 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
The inputs used to determine the fair value of the embedded derivative liabilities are as follows:
2021 Convertible Note Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield— %— %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
AFG Convertible Notes Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield— %— %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
Schedule of Liabilities Measured at Fair Value The following table summarizes the changes in the fair value of liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and are designated as Level 3:
Three Months Ended March 31,

2024
2023
Embedded derivatives
Balance at beginning of the period$4,423 $1,945 
Additions— 14,799 
Change in fair value of derivatives - related parties1
(534)4,511 
Balance at end of the period$3,889 $21,255 
Warrants
Balance at beginning of the period$27,406 $— 
Additions— — 
Change in fair value of warrants
(2,894)— 
Balance at end of the period$24,512 $— 
1 Includes loss on debt extinguishment from Yorkville Promissory Note Conversions for the three months ended March 31, 2023.
Schedule of Estimated Fair Value of Financial Instruments Not Carried at Fair Value
The estimated fair value of financial instruments not carried at fair value in the Unaudited Condensed Consolidated Balance Sheets was as follows:
Level in Fair Value Hierarchy
March 31, 2024
December 31, 2023
Carrying ValueFair ValueCarrying ValueFair Value
Notes receivable3$827 $721 $863 $719 
2021 Convertible Note*
396,033 63,034 94,386 57,998 
Senior Secured Term Loan 386,756 64,117 85,624 61,360 
AFG Convertible Notes*317,917 19,076 18,139 18,352 
Equipment financing facility34,924 4,261 5,710 4,826 
  Total$206,457 $151,209 $204,722 $143,255 
*Includes the embedded derivative liabilities.
v3.24.1.1.u2
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Stock-based compensation expense included in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows:
Three Months Ended March 31,
2024
2023
Stock options$174 $740 
Restricted stock units2,767 2,623 
Total$2,941 $3,363 
v3.24.1.1.u2
Shareholders’ Deficit (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Anti-Dilutive Shares Excluded From Diluted Net Loss Per Share
The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:

Three Months Ended March 31,
2024
2023
Stock options and restricted stock units9,048,602 6,987,945 
Warrants
61,411,393 7,326,654 
Convertible Notes
16,226,124 16,950,606 
v3.24.1.1.u2
Overview (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
segment
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Aug. 31, 2023
USD ($)
Line of Credit Facility [Line Items]        
Number of operating segments | segment 1      
Number of reportable segments | segment 1      
Net loss $ 46,708 $ 71,600    
Net cash used in operating activities 40,474 30,478    
Accumulated deficit 922,554   $ 875,846  
Cash and cash equivalents 31,773 $ 16,127 $ 69,473  
Working capital 22,097      
Outstanding debt $ 3,458      
DOE Clean Energy Financing Program | Notes Payable        
Line of Credit Facility [Line Items]        
Aggregate principal amount       $ 398,600
v3.24.1.1.u2
Summary of Significant Accounting Policies (Details)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Equity interest ownership percentage 100.00%
v3.24.1.1.u2
Revenue Recognition - Revenue Recognition (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Total revenue $ 6,601 $ 8,835
Product revenue    
Disaggregation of Revenue [Line Items]    
Total revenue 6,501 8,675
Service revenue    
Disaggregation of Revenue [Line Items]    
Total revenue $ 100 $ 160
v3.24.1.1.u2
Revenue Recognition - Narratives (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Sales-type lease, term of contract 20 years    
Sales-type lease, revenue $ 0 $ 0  
Increase (decrease) in contract asset 4,572 1,914  
Increase (decrease) in contract liabilities 501 $ (3,450)  
Revenue recognized in contract liabilities 798    
Increase from customer advance payments 1,299    
Contract liabilities, current 2,828   $ 3,070
Contract liabilities, long-term 4,283   $ 3,540
Contract assets, current 11,075    
Contract assets, long-term $ 1,819    
Revenue Benchmark | Customer 1 | Customer Concentration Risk      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Concentration risk percentage 88.10% 97.00%  
v3.24.1.1.u2
Revenue Recognition - Information about Contract Liabilities from Contracts with Customers (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]    
Contract assets $ 12,894 $ 8,322
Contract liabilities $ 7,111 $ 6,610
v3.24.1.1.u2
Cash, Cash Equivalents and Restricted Cash - Narrative (Details)
Jul. 29, 2022
interest_payment
Senior Secured Term Loan | Secured Debt  
Restricted Cash and Cash Equivalents Items [Line Items]  
Number of immediately following interest payments required to be escrowed 4
v3.24.1.1.u2
Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]        
Cash and cash equivalents $ 31,773 $ 69,473 $ 16,127  
Restricted cash - current 2,625 3,439 2,725  
Long-term restricted cash 11,858 11,755 11,450  
Total cash, cash equivalents and restricted cash $ 46,256 $ 84,667 $ 30,302 $ 31,223
v3.24.1.1.u2
Inventory (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 13,045 $ 15,487
Work-in-process 490 1,105
Finished goods 858 478
Total inventory, net $ 14,393 $ 17,070
v3.24.1.1.u2
Property, Plant and Equipment, Net - Components of Property and Equipment (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 61,803 $ 55,887
Less: Accumulated depreciation (19,061) (18,032)
Total property, plant and equipment, net 42,742 37,855
Equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 22,484 20,559
Equipment | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated Useful lives 5 years  
Equipment | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated Useful lives 10 years  
Finance lease    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 504 504
Estimated Useful lives 5 years  
Furniture    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 2,179 2,103
Furniture | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated Useful lives 5 years  
Furniture | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated Useful lives 10 years  
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 7,951 7,718
Tooling    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 7,866 7,045
Tooling | Minimum    
Property, Plant and Equipment [Line Items]    
Estimated Useful lives 2 years  
Tooling | Maximum    
Property, Plant and Equipment [Line Items]    
Estimated Useful lives 3 years  
Construction in progress (“CIP”)    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 20,819 $ 17,958
v3.24.1.1.u2
Property, Plant and Equipment, Net - Narratives (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Property, Plant and Equipment [Abstract]    
Depreciation expense related to property and equipment $ 1,175 $ 2,667
Loss from write-down of property, plant and equipment 65 760
Interest costs $ 850 $ 0
v3.24.1.1.u2
Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Capitalized cost $ 146  
Additional capitalized cost 8  
Amortization of capitalized computer software cost 12 $ 9
Patents    
Finite-Lived Intangible Assets [Line Items]    
Gross patents value $ 400  
Patents useful lives 10 years  
Patents amortization expenses $ 10 $ 10
Software    
Finite-Lived Intangible Assets [Line Items]    
Patents useful lives   3 years
v3.24.1.1.u2
Notes Receivable, Net and Variable Interest Entities (“VIEs”) Consideration (Details) - Variable Interest Entity, not primary beneficiary - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Variable Interest Entity [Line Items]    
Loan commitment on the consolidated balance sheet $ 827 $ 863
Financing receivable, allowance for credit loss $ 36 $ 2
v3.24.1.1.u2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accrued payroll $ 7,273 $ 4,553
Warranty reserve 5,513 6,197
Accrued legal and professional expenses 11,058 10,710
Provision for contract losses 3,205 3,351
Insurance premium payable, current 2,730 2,605
Interest payable, current 3,684 0
Other 5,151 4,916
Total accrued expenses $ 38,614 $ 32,332
v3.24.1.1.u2
Accrued Expenses - Warranty Reserve Activity (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]    
Warranty reserve - beginning of period $ 6,197 $ 3,836
Additions for current period deliveries 265 357
Changes in the warranty reserve estimate (949) 0
Warranty costs incurred 0 (221)
Warranty reserve - end of period $ 5,513 $ 3,972
v3.24.1.1.u2
Government Grants (Details) - Production Tax Credits - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Government Assistance [Line Items]      
Government assistance amount $ 1,542 $ 798  
Current grants receivable $ 4,798   $ 3,256
v3.24.1.1.u2
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended
Jul. 31, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Jan. 31, 2023
Jan. 18, 2023
Jul. 06, 2021
Related Party Transaction [Line Items]              
Warrants outstanding (in shares)   54,359,139   54,359,139      
Warrants liability   $ 24,561,000   $ 27,461,000      
2021 Convertible Note Payable | Convertible Notes              
Related Party Transaction [Line Items]              
Principal             $ 100,000,000
Related Party              
Related Party Transaction [Line Items]              
Payment made for debt issuance cost   $ 0 $ 1,116,000        
Related Party | IPO warrants | Common Stock              
Related Party Transaction [Line Items]              
Warrants outstanding (in shares)   274,400   274,400      
Warrants liability   $ 49,000   $ 55,000      
Related Party | 2021 Convertible Note Payable              
Related Party Transaction [Line Items]              
Notes payable $ 100,000,000            
Payment made for debt issuance cost $ 3,000,000            
Related Party | AFG Convertible Notes Payable | Convertible Notes              
Related Party Transaction [Line Items]              
Principal         $ 13,750,000 $ 13,750,000  
Paid-in-kind interest rate   26.50%     26.50%    
v3.24.1.1.u2
Borrowings - Schedule of Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Borrowing Outstanding    
Total borrowings $ 238,175 $ 238,962
Current portion 3,458 3,332
Total borrowings, non-current 234,717 235,630
Carrying Value*    
Total borrowings 205,630 203,859
Current portion 3,458 3,332
Total borrowings, non-current 202,172 200,527
2021 Convertible Note Payable | Convertible Notes    
Borrowing Outstanding    
Total borrowings 115,815 115,815
Carrying Value*    
Total borrowings 96,033 94,386
Senior Secured Term Loan    
Carrying Value*    
Total borrowings 86,756 85,624
Senior Secured Term Loan | Secured Debt    
Borrowing Outstanding    
Total borrowings 100,000 100,000
Carrying Value*    
Total borrowings 86,756 85,624
AFG Convertible Notes | Convertible Notes    
Borrowing Outstanding    
Total borrowings 17,429 17,429
Carrying Value*    
Total borrowings 17,917 18,139
Equipment financing facility    
Carrying Value*    
Total borrowings 4,924 5,710
Equipment financing facility | Line of Credit    
Borrowing Outstanding    
Total borrowings 4,931 5,718
Carrying Value*    
Total borrowings $ 4,924 $ 5,710
v3.24.1.1.u2
Borrowings - Narrative (Details) - USD ($)
3 Months Ended 4 Months Ended
Jul. 29, 2022
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2023
Dec. 31, 2023
Jan. 31, 2023
Jan. 18, 2023
Sep. 30, 2022
Sep. 30, 2021
Jul. 06, 2021
Debt Instrument [Line Items]                    
Interest payable   $ 2,892,000     $ 0          
Common stock, par value (in dollars per share)   $ 0.0001     $ 0.0001          
Carrying Value   $ 205,630,000     $ 203,859,000          
Long-term debt, current   3,458,000     3,332,000          
Proceeds from issuance of convertible notes - related party   0 $ 33,350,000              
Loss on debt extinguishment   0 1,634,000              
Change in fair value of derivatives - related parties   534,000 (12,934,000)              
Related Party                    
Debt Instrument [Line Items]                    
Change in fair value of derivatives - related parties   534,000 (12,934,000)              
2021 Convertible Note Payable | Related Party                    
Debt Instrument [Line Items]                    
Interest payable   1,737,000     0          
2021 Convertible Note Payable | Convertible Notes                    
Debt Instrument [Line Items]                    
Principal                   $ 100,000,000
Embedded conversion feature   46,000     78,000          
Carrying Value   96,033,000     $ 94,386,000          
Non-cash interest expense - related party   $ 3,416,000 2,961,000              
Coupon Interest Rate   40.00%     40.00%          
Amortization of debt discount   $ 1,531,000 1,207,000              
AFG Convertible Notes Payable | Related Party                    
Debt Instrument [Line Items]                    
Interest payable   $ 1,155,000     $ 0          
Carrying Value             $ 16,623,000      
Non-cash interest expense - related party     2,873,000              
AFG Convertible Notes Payable | Convertible Notes                    
Debt Instrument [Line Items]                    
Common stock, par value (in dollars per share)             $ 0.0001      
Conversion price per unit (in dollars per share)             $ 1.67      
Coupon Interest Rate   40.00%     40.00%          
AFG Convertible Notes Payable | Convertible Notes | Related Party                    
Debt Instrument [Line Items]                    
Principal           $ 13,750,000 $ 13,750,000      
Paid-in-kind interest rate   26.50%       26.50%        
Embedded conversion feature   $ 3,843,000     $ 4,345,000          
Carrying Value   17,917,000     18,139,000          
Non-cash interest expense - related party   1,435,000 969,000              
Amortization of debt discount   218,000 148,000              
Senior Secured Term Loan                    
Debt Instrument [Line Items]                    
Carrying Value   86,756,000     85,624,000          
Senior Secured Term Loan | SOFR | Minimum                    
Debt Instrument [Line Items]                    
Variable rate spread 0.2616%                  
Senior Secured Term Loan | NYFRB | Minimum                    
Debt Instrument [Line Items]                    
Variable rate spread 0.50%                  
Senior Secured Term Loan | Secured Debt                    
Debt Instrument [Line Items]                    
Principal $ 100,000,000                  
Carrying Value   86,756,000     85,624,000          
Number of days prior to current maturity date 91 days                  
Minimum prepayment amount $ 500,000,000                  
Repayment applicable treasury rate 0.50%                  
Interest escrowed for loan   $ 11,858,000     11,755,000          
Senior Secured Term Loan | SOFR Loans                    
Debt Instrument [Line Items]                    
Variable rate spread 8.50%                  
Coupon Interest Rate   14.11%                
Senior Secured Term Loan | ABR Loans                    
Debt Instrument [Line Items]                    
Stated interest rate 7.50%                  
Equipment financing facility                    
Debt Instrument [Line Items]                    
Carrying Value   $ 4,924,000     5,710,000          
Non-cash interest expense - related party   208,000 317,000              
Long-term line of credit   4,924,000     5,710,000          
Long-term debt, current   3,458,000     3,332,000          
Equipment financing facility | Line of Credit                    
Debt Instrument [Line Items]                    
Carrying Value   $ 4,924,000     $ 5,710,000          
Coupon Interest Rate               16.20% 14.30%  
Maximum borrowing capacity                 $ 25,000,000  
Yorkville Convertible Promissory Note | Convertible Notes | Related Party                    
Debt Instrument [Line Items]                    
Proceeds from issuance of convertible notes - related party       $ 22,000,000            
Amortization of debt discount     $ 6,952,000              
Converted instrument, shares issued (in shares)     11,216,492              
Embedded Derivatives - Yorkville Convertible Promissory Notes | Convertible Notes                    
Debt Instrument [Line Items]                    
Change in fair value of derivatives - related parties     $ 55,000              
v3.24.1.1.u2
Borrowings - Interest Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
2021 Convertible Note Payable | Convertible Notes    
Debt Instrument [Line Items]    
Contractual interest expense $ 1,737 $ 1,637
Amortization of debt discount 1,531 1,207
Amortization of debt issuance costs 148 117
Total 3,416 2,961
AFG Convertible Notes | Related Party    
Debt Instrument [Line Items]    
Total   2,873
AFG Convertible Notes | Convertible Notes | Related Party    
Debt Instrument [Line Items]    
Contractual interest expense 1,155 779
Amortization of debt discount 218 148
Amortization of debt issuance costs 62 42
Total 1,435 969
Senior Secured Term Loan | Secured Debt | Nonrelated Party    
Debt Instrument [Line Items]    
Contractual interest expense 3,684 3,373
Amortization of debt discount 115 93
Amortization of debt issuance costs 1,017 822
Total $ 4,816 $ 4,288
v3.24.1.1.u2
Borrowings - Net Carrying Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Jan. 18, 2023
Debt Instrument [Line Items]      
Principal $ 238,175 $ 238,962  
Total borrowings 205,630 203,859  
2021 Convertible Note Payable | Convertible Notes      
Debt Instrument [Line Items]      
Principal 115,815 115,815  
Unamortized debt discount (18,081) (19,612)  
Unamortized debt issuance costs (1,747) (1,895)  
Embedded conversion feature 46 78  
Total borrowings 96,033 94,386  
AFG Convertible Notes Payable | Related Party      
Debt Instrument [Line Items]      
Total borrowings     $ 16,623
AFG Convertible Notes Payable | Convertible Notes | Related Party      
Debt Instrument [Line Items]      
Principal 17,429 17,429  
Unamortized debt discount (2,617) (2,835)  
Unamortized debt issuance costs (738) (800)  
Embedded conversion feature 3,843 4,345  
Total borrowings 17,917 18,139  
Senior Secured Term Loan      
Debt Instrument [Line Items]      
Total borrowings 86,756 85,624  
Senior Secured Term Loan | Secured Debt      
Debt Instrument [Line Items]      
Principal 100,000 100,000  
Total borrowings 86,756 85,624  
Senior Secured Term Loan | Secured Debt | Nonrelated Party      
Debt Instrument [Line Items]      
Principal 100,000 100,000  
Unamortized debt discount (1,344) (1,459)  
Unamortized debt issuance costs (11,900) (12,917)  
Total borrowings $ 86,756 $ 85,624  
v3.24.1.1.u2
Borrowings - Equipment Financing Facility (Details) - Line of Credit - Equipment financing facility - USD ($)
$ in Thousands
1 Months Ended 31 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2024
Debt Instrument [Line Items]      
Gross Amount of Initial Draw $ 4,216 $ 7,000 $ 11,216
Coupon Interest Rate 16.20% 14.30%  
Debt Issuance Costs $ 96 $ 175 $ 271
v3.24.1.1.u2
Warrants Liability - Narrative (Details) - shares
1 Months Ended 3 Months Ended
Dec. 31, 2023
May 31, 2023
Apr. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
May 22, 2020
Class of Warrant or Right [Line Items]            
Common stock to be purchased through warrants (in shares)           9,075,000
Common Stock            
Class of Warrant or Right [Line Items]            
Issuance of common stock (in shares)       7,239,982 11,900,400  
Related Party | Common Stock | April 2023 warrants            
Class of Warrant or Right [Line Items]            
Issuance of common stock (in shares)     16,000,000      
Common stock to be purchased through warrants (in shares)     16,000,000      
Related Party | Common Stock | May 2023 warrants            
Class of Warrant or Right [Line Items]            
Issuance of common stock (in shares)   3,601,980        
Common stock to be purchased through warrants (in shares)   3,601,980        
Related Party | Common Stock | December 2023 warrants            
Class of Warrant or Right [Line Items]            
Issuance of common stock (in shares) 34,482,759          
v3.24.1.1.u2
Warrants Liability - Schedule of Common Stock Warrants Outstanding and Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Class of Warrant or Right [Line Items]    
Warrants outstanding (in shares) 54,359,139 54,359,139
Fair Value $ 24,561 $ 27,461
IPO warrants | Related Party | Common Stock    
Class of Warrant or Right [Line Items]    
Warrants outstanding (in shares) 274,400 274,400
Fair Value $ 49 $ 55
April 2023 warrants | Related Party | Common Stock    
Class of Warrant or Right [Line Items]    
Warrants outstanding (in shares) 16,000,000 16,000,000
Fair Value $ 5,494 $ 6,276
May 2023 warrants | Related Party | Common Stock    
Class of Warrant or Right [Line Items]    
Warrants outstanding (in shares) 3,601,980 3,601,980
Fair Value $ 1,357 $ 1,544
December 2023 warrants | Related Party | Common Stock    
Class of Warrant or Right [Line Items]    
Warrants outstanding (in shares) 34,482,759 34,482,759
Fair Value $ 17,661 $ 19,586
v3.24.1.1.u2
Fair Value Measurement - Fair Value of Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants $ 24,561 $ 27,461
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants 0 0
Level 1 | Embedded derivatives    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Embedded derivatives 0 0
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants 49 55
Level 2 | Embedded derivatives    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Embedded derivatives 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants 24,512 27,406
Level 3 | Embedded derivatives    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Embedded derivatives $ 3,889 $ 4,423
v3.24.1.1.u2
Fair Value Measurement - Assumptions used to determine Fair Value of Warrants (Details)
Mar. 31, 2024
$ / shares
Dec. 31, 2023
$ / shares
Time to expiration | April 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Time to expiration 4 years 6 months 14 days 4 years 9 months 14 days
Time to expiration | May 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Time to expiration 4 years 3 months 14 days 4 years 6 months 14 days
Time to expiration | December 2023 Private Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Time to expiration 4 years 8 months 15 days 4 years 11 months 15 days
Common stock price | April 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 1.03 1.09
Common stock price | May 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 1.03 1.09
Common stock price | December 2023 Private Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 1.03 1.09
Risk-free interest rate | April 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 0.042 0.038
Risk-free interest rate | May 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 0.042 0.038
Risk-free interest rate | December 2023 Private Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 0.042 0.038
Volatility | April 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 0.700 0.700
Volatility | May 2023 warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 0.700 0.700
Volatility | December 2023 Private Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Warrants and rights outstanding, measurement input 0.700 0.700
v3.24.1.1.u2
Fair Value Measurement - Assumptions used to determine Fair Value of Embedded Derivative Liabilities (Details) - Convertible Notes
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
2021 Convertible Note Payable    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Term 2 years 3 months 2 years 6 months
Effective debt yield 40.00% 40.00%
2021 Convertible Note Payable | Dividend yield    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value, measurement input 0 0
2021 Convertible Note Payable | Risk-free interest rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value, measurement input 0.045 0.041
2021 Convertible Note Payable | Volatility    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value, measurement input 0.700 0.700
AFG Convertible Notes Payable    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Term 2 years 3 months 2 years 6 months
Effective debt yield 40.00% 40.00%
AFG Convertible Notes Payable | Dividend yield    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value, measurement input 0 0
AFG Convertible Notes Payable | Risk-free interest rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value, measurement input 0.045 0.041
AFG Convertible Notes Payable | Volatility    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value, measurement input 0.700 0.700
v3.24.1.1.u2
Fair Value Measurement - Liabilities Measured at Fair Value (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Warrants    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance at beginning of the period $ 27,406 $ 0
Additions 0 0
Change in fair value of derivatives and warrants (2,894) 0
Balance at end of the period 24,512 0
Embedded derivatives    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance at beginning of the period 4,423 1,945
Additions 0 14,799
Change in fair value of derivatives and warrants (534) 4,511
Balance at end of the period $ 3,889 $ 21,255
v3.24.1.1.u2
Fair Value Measurement - Estimated Fair Value of Financial Instruments Not Carried at Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Carrying Value $ 205,630 $ 203,859
Carrying Value 206,457 204,722
Notes receivable    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Carrying Value 827 863
2021 Convertible Note    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Carrying Value 96,033 94,386
Senior Secured Term Loan    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Carrying Value 86,756 85,624
AFG Convertible Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Carrying Value 17,917 18,139
Equipment financing facility    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Carrying Value 4,924 5,710
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 151,209 143,255
Level 3 | Notes receivable    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 721 719
Level 3 | 2021 Convertible Note    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 63,034 57,998
Level 3 | Senior Secured Term Loan    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 64,117 61,360
Level 3 | AFG Convertible Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value 19,076 18,352
Level 3 | Equipment financing facility    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value $ 4,261 $ 4,826
v3.24.1.1.u2
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
Feb. 01, 2024
Jan. 31, 2024
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]      
Future lease payments     $ 5,568
Settlement, amount awarded to other party $ 8,500    
Payments for legal settlements   $ 1,000  
Litigation settlement amount funded by liability insurance policies $ 7,500    
v3.24.1.1.u2
Stock-Based Compensation - Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock compensation expense $ 2,941 $ 3,363
Stock options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock compensation expense 174 740
Restricted stock units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock compensation expense $ 2,767 $ 2,623
v3.24.1.1.u2
Stock-Based Compensation - Narratives (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock compensation expense $ 12,448
Unrecognized stock compensation expense attributable to stock option 90
Restricted stock units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock compensation expense attributable to RSUs $ 12,358
Vesting term 2 years 1 month 6 days
Stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting term 1 month 6 days
v3.24.1.1.u2
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Income tax expense $ 25 $ 10
v3.24.1.1.u2
Shareholders’ Deficit - Narrative (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
vote
$ / shares
shares
Mar. 31, 2023
USD ($)
shares
Dec. 31, 2023
$ / shares
shares
Dec. 31, 2022
shares
May 22, 2020
$ / shares
shares
Class of Stock [Line Items]          
Preferred stock, shares authorized (in shares) 1,000,000   1,000,000    
Preferred stock, shares issued (in shares) 0   0    
Preferred stock, shares outstanding (in shares) 0   0    
Common stock, shares authorized (in shares) 300,000,000   300,000,000    
Common stock, par value (in dollars per share) | $ / shares $ 0.0001   $ 0.0001    
Number of votes for each share | vote 1        
Common stock, shares issued (in shares) 206,779,447   199,133,827    
Common stock, shares outstanding (in shares) 206,779,447   199,133,827    
Cancellation of shares used to settle payroll tax withholding | $ $ 308,000 $ 345,000      
Common stock to be purchased through warrants (in shares)         9,075,000
Price of common stock to be purchased through warrants (in dollars per share) | $ / shares         $ 11.50
Warrants outstanding (in shares) 54,359,139   54,359,139    
Public Warrants          
Class of Stock [Line Items]          
Warrants outstanding (in shares) 7,052,254   7,052,254    
Private Placement          
Class of Stock [Line Items]          
Proceeds from sale of treasury stock | $   $ 20,850,000      
Sale of stock, number of shares issued in transaction (in shares)   11,900,400      
ATM          
Class of Stock [Line Items]          
Sale of stock, number of shares issued in transaction (in shares) 7,239,982 0      
Authorized value of stock to be sold | $ $ 200,000        
Cash received on issuance of shares | $ $ 7,206,000        
Sale of stock, price per share (in dollars per share) | $ / shares $ 1.03        
Common Stock          
Class of Stock [Line Items]          
Common stock, shares outstanding (in shares) 206,779,447 95,222,670 199,133,827 82,653,781  
Exercise of warrants (in shares) 0 0      
v3.24.1.1.u2
Shareholders’ Deficit - Potentially Dilutive Shares Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Stock options and restricted stock units    
Class of Stock [Line Items]    
Anti-dilutive securities excluded from calculation of diluted net loss per share (in shares) 9,048,602 6,987,945
Warrants    
Class of Stock [Line Items]    
Anti-dilutive securities excluded from calculation of diluted net loss per share (in shares) 61,411,393 7,326,654
Convertible Notes    
Class of Stock [Line Items]    
Anti-dilutive securities excluded from calculation of diluted net loss per share (in shares) 16,226,124 16,950,606
v3.24.1.1.u2
Subsequent Events (Details) - USD ($)
$ in Thousands
Apr. 22, 2024
Mar. 31, 2024
Dec. 31, 2023
Subsequent Event [Line Items]      
Grant receivable   $ 4,798 $ 3,256
Subsequent event | Production Tax Credits      
Subsequent Event [Line Items]      
Grant receivable $ 2,303    

Eos Energy Enterprises (NASDAQ:EOSEW)
Historical Stock Chart
From May 2024 to May 2024 Click Here for more Eos Energy Enterprises Charts.
Eos Energy Enterprises (NASDAQ:EOSEW)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Eos Energy Enterprises Charts.